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I Introduction
I.1 Overview
I.1.1 Motivation and organization
Kilovoltage (kV) energy x-rays are used with increased frequency in medicine to
aid in both the diagnosis and treatment of disease. For example, there has been a rapid
increase in the number of computed tomography (CT) examinations performed annually in
the United States, with an estimated 62 million individual procedures performed in 2006, up
from around 10-12 million in 1990 [19]. While the diagnostic information provided by x-ray
imaging is often critical for patient care, there are significant concerns about the risks of
carcinogenesis from the increased radiation exposure to patients from imaging [14, 15, 17–
19, 43].
In addition to their diagnostic utility, kilovoltage energy x-rays are useful for treat-
ing superficial tumors on or near the surface of the body such as skin cancers, kaposi’s
sarcoma, and certain non-cancerous lesions such as keloids.
Due to the frequent use of kilovoltage energy x-rays in medicine there is a need
to calculate the radiation dose to patients from these procedures. Existing techniques com-
monly used for clinical dose calculation are inadequate for this application. Model-based
convolution/superposition algorithms are universally utilized for 3-dimensional dose calcula-
tions for radiation therapy treatment planning. These algorithms have become the standard
for clinical radiotherapy dose calculations due to their high degree of accuray, efficiency, and
ease of implementation. Current model-based dose calculation algorithms implemented in
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commercial radiotherapy treatment planning systems, however, are inaccurate for kilovolt-
age photon beams as these techniques were designed with approximations appropriate for
megavoltage (MV) photon beams that are not applicable in the kilovoltage energy range.
Due to the widespread use of model-based convolution/superposition algorithms
in radiation therapy clinics for patient-specific dose calculations it is desireable to extend
this approach to the kilovoltage energy range. In this dissertation we present a new model-
based convolution/superposition dose calculation algorithm for kilovoltage x-rays developed
to overcome the limitations of existing algorithms for these energies. This algorithm has
the potential for clinical implementation to calculate the radiation dose to patients from
imaging procedures such as computed tomography and fluoroscopy as well as for kilovoltage
energy radiation therapy treatments.
In the following sections we review the basics of radiation dose and model-based
convolution/superposition algorithms.This is followed by a discussion of the previous work
done in kilovoltage dosimetry for both therapeutic and diagnostic procedures. Lastly, we
develop the new calculation algorithm for kilovoltage energy x-rays and present benchmark
calculations testing it for the specific cases of calculating the dose to real patients from
kilovoltage cone-beam CT (kV-CBCT) and single-angle projection imaging. These test
cases were chosen due to their increased utility for patient set up for image-guided radiation
therapy (IGRT).
I.1.2 Radiation dose
In radiological physics the parameter that is typically correlated with the phys-
iological effects of radiation is absorbed dose, defined as the energy imparted to matter
per unit mass. The SI unit of absorbed dose is the Gray (Gy, 1 Gy=1 J/kg). Radiation
2
therapy and diagnostic imaging frequently use high-energy photon beams for therapeutic
and diagnostic procedures. The interactions of these high energy photons in tissue produce
a shower of primary electrons. The local energy deposition in tissue from these interactions
is the fraction of the primary electron kinetic energy that is lost to tissue while traveling
minus any radiative losses due to bremsstrahlung radiation and characteristic x-rays.
Under specific conditions the absorbed dose can be expressed simply in terms of
the incident photon fluence and the properties of the absorbing medium. For a single mass
element, if the conditions of charged-particle equilibrium are met, i.e.:
1. The atomic composition of the absorbing medium is homogeneous;
2. The density of the absorbing medium is homogeneous;
3. There exists a uniform field of indirectly ionizing radiation such as photons;
4. No inhomogeneous electric or magnetic fields are present;
then the absorbed dose can be written as:
D =
∫
E · φ (E) ·
(
µen (E)
ρ
)
dE. (I.1)
Here E is the photon energy, φ (E) is the photon fluence, and (µen (E) /ρ) is the mass-energy
absorption coefficient of the absorbing media. For medical applications of ionizing radiation
the primary contributions to the mass-energy absorption coefficient are the photoelectric
effect, Compton scattering, and e−e+ pair production. Figure I.1 shows the dependence of
the mass-energy absorption coefficient of water on photon energy, and the energy regions
where each of these three interactions dominate the photon interaction cross section.
Medical linear accelerators (linacs) used in radiotherapy produce x-ray beams spec-
ified by the electric potential used to accelerate electrons to a target, which is typically in
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Figure I.1: Mass-energy absorption coefficient of water as a function of photon energy. The
photoelectric effect dominates the photon cross section for energies less than about 20 keV.
Compton scattering is the dominant interaction from this energy until about 20 MeV where
pair production dominates. (Data from NIST [62])
the 4–25 MV range. The average energy in MeV of the resulting bremsstrahlung radia-
tion which makes up the treatment beam is roughly 3 times smaller than the accelerating
potential. As seen in Fig. I.1, the dominant photon interaction in water at these energies
is Compton scattering. Diagnostic imaging procedures, on the other hand, typically use
kilovoltage x-rays since they provide greater contrast between the tissues in the body than
megavoltage x-rays. This is largely due to the strong dependence of the photoelectric effect
on the atomic number of the absorbing material. Fig I.2 shows the energy spectra for repre-
sentative cone-beam computed tomography (CBCT) x-ray beams with maximum energies
ranging from 60 to 125 keV.
4
Figure I.2: Energy spectra of kV-CBCT x-ray beams with various accelerating potentials
and filters. (Reproduced from [32] with permission)
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I.1.3 Model-based convolution/superposition dose calculations
Therapeutic applications of radiation typically require radiation doses that are
in general extremely high (on the order of tens of Gray) and precisely targeted. Conse-
quentially, sophisticated model-based convolution/superposition dose calculation algorithms
have been developed for clinical use that provide three dimensional dose distributions based
on patient-specific anatomy and custom designed treatment fields. The basis of these tech-
niques is to express the dose distribution as a convolution of the incident photon fluence
with the spatial distribution of the energy deposited in medium due to photon interactions.
Figure I.3 shows the mass-energy absorption coefficients for bone and soft-tissue as
a function of energy. In the therapeutic energy range the mass-energy absorption coefficient
is nearly equivalent for all tissues in the body regardless of composition, and is roughly
equivalent to that of water. This considerably simplifies dose calculation as the energy
released due to the interaction of a photon field is independent of the atomic composition
of the medium, and scales directly with density for a given photon fluence [63]. This
simplification motivated the development of volumetric x-ray dose calculation methods in
which the dose is calculated as a convolution of the photon fluence φ (r′, E) and a dose
deposition kernel k (r − r′) [13, 59]:
D (r) =
∫∫
φ (r′;E) · k (r − r′;E) dV ′dE. (I.2)
The dose deposition kernels characterize the fraction of the energy released at r′ that is
absorbed at r. Kernels are typically generated using Monte Carlo simulations in which
photons are forced to interact at the center of a water calculation phantom and the spatial
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Figure I.3: Mass-energy absorption coefficients for bone and soft-tissue. The insert shows
the quotient of the bone mass-energy absorption coefficient to that of water in the diagnostic
energy range. (Data from NIST [62])
distribution of the deposited dose is recorded [58]. Due to the near equality of the mass-
energy absorption coefficients of all tissues in the body at megavoltage energies, kernels
generated in water are capable of describing the deposited dose distribution in all tissues
from interactions with megavoltage energy x-rays.
In the model-based convolution/superposition approach, calculation of the radi-
ation dose is performed in three steps: (1) modelling the treatment head and collimation
systems of the linac to provide the incident fluence based on the the treatment plan [54, 68],
(2) determining the x-ray fluence distribution in the patient, and (3) convolving the fluence
with the dose deposition kernels. The first part of the calculation requires commission-
ing the x-ray beams delivered by the linac in a treatment planning system so that x-ray
fluences can be determined for the treatment fields designed by the treatment planner.
The commissioning process consists of performing extensive beam measurements including
7
percent-depth-dose curves, lateral beam profiles, and relative output factors as a function
of field size, and supplying these data to the planning system to build the beam model.
The second part of the calculation requires detailed knowledge of the patient
anatomy so that attenuation of the beam within the patient can be calculated. This data
is obtained from CT images taken of the patient prior to radiotherapy specifically for the
purpose of treatment planning. For megavoltage x-ray beams the necessary information
to extract from the CT data is the distribution of electron densities within the patient.
As a CT image is obtained from the absorption of x-rays within the body, it provides a
three-dimensional map of the linear attenuation coefficients of the materials being imaged.
Customarily, these values are reported as CT numbers or Houndsfield units, which are
defined relative to the linear attenuation coefficient of water:
CT Number =
µ− µH2O
µH2O
× 1000 (I.3)
To correlate the CT number with electron density, a CT number to density cali-
bration curve is obtained for a CT unit by imaging a phantom consisting of various known
materials and correlating the resulting CT numbers with the known densities of the ma-
terials (Fig. I.4). In convolution/superposition dose calculations the densities are used for
attenuation of the primary beam and for scaling the length between an interaction site and
dose calculation site, r − r′, in order to apply the dose deposition kernel to media with
density inhomogeneities.
Model-based convolution/superposition algorithms have been shown to be highly
accurate for megavoltage calculations in a wide variety of situations [7, 39, 41, 44, 55, 56].
Due to their accuracy and speed relative to other calculation methods they have become
the standard approach to clinical dose calculation for external beam photon therapy.
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Figure I.4: Example of a CT number to electron density calibration curve used in a ra-
diotherapy treatment planning system. The calibration curve was obtained for a 120 kVp
beam from a GE LightSpeed R© 16 CT scanner (General Electric Company, Fairfield, CT)
using a GAMMEX 467 R© Tissue Characterization Phantom (GAMMEX, Inc., Middleton,
WI).
These algorithms, however, are limited to megavoltage energies since the technique
requires that the mass-energy absorption coefficients of the different absorbing media be
equivalent. At kilovoltage energies, photoabsorption introduces a strong atomic number
dependence on the photon interaction cross section. As Table I.1 shows, most materials
in the body have similar effective atomic numbers; the atomic number of bone, however,
is significantly higher than that of soft-tissues. This results in the enhanced mass-energy
absorption coefficient of bone over soft-tissue that is seen in Fig. I.3 for photons in the
kilovoltage energy range. Dose deposition kernels obtained in water calculation phantoms
for kV x-rays are thus not be applicable in regions in or near bone.
To illustrate the shortcomings of the convolution/superposition technique for kilo-
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Table I.1: Effective atomic numbers of tissues in the human body. (Data from [45])
Material Effective Atomic Number
Air 7.6
Water 7.4
Muscle 7.4
Fat 5.9–6.3
Bone 11.6–13.8
voltage x-rays Figure. I.5 shows results of dose calculations performed for a kilovoltage cone-
beam computed tomography scan of a pediatric head-and-neck patient with both Monte
Carlo and model-based convolution/superposition techniques. The Monte Carlo calculation
fully accounts for the photoabsorption of the x-ray beam as it travels through the skull of the
patient. This leads to drastically increased dose to bone relative to the adjacent soft-tissue.
The model-based calculation neglects photoabsorption and significantly underestimates the
dose to bone. The dose to soft-tissues is overestimated with this technique since the calcu-
lation does not account for the reduced x-ray fluence in the body due to photoabsorption
in bone.
I.1.4 Overview of the new algorithm
To extend the applicability of model-based dose calculation algorithms to the cal-
culation of dose from kV x-rays it will be necessary to account for the perturbations to the
calculated dose distributions due to medium-atomic number dependent effects. The new
radiation dose calculation that we develop for kilovoltage energy x-rays calculates the radi-
ation dose-to-medium including the effects of photoabsorption in bone in two steps. First,
the radiation dose-to-water is calculated using a model-based convolution/superposition
technique. This calculation utilizes a newly introduced, empirically parameterized scatter
dose kernel, and accounts for density inhomogeneities in the calculation volume with a
newly developed kernel-scaling approach. This calculation ignores medium atomic number
10
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Figure I.5: (a) An axial slice through a pediatric head-and-neck CT scan. (b and c) Axial
dose planes in colorwash calculated for a CBCT scan taken for this patient with Monte
Carlo and model-based convolution/superposition. Dose was normalized to the maximum
dose to the scanned body. (d) Horizontal dose profiles for the line in (a).
dependent effects. The development of the model-based dose-to-water calculation algorithm
is presented in chapter II. The second step of the calculation is to account for the medium
atomic number dependent effects by applying a medium-dependent correction factor dis-
tribution to the dose-to-water calculation. We develop two methods to obtain patient and
procedure-specific medium-dependent correction factor distributions that are presented in
chapter III. In chapter IV we combine the model-based dose-to-water calculation with the
medium-dependent correction method to calculate the dose-to-medium to real patients from
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kilovoltage x-ray imaging procedures.
I.2 Previous work in kV dosimetry
I.2.1 Radiation dose calculation methods in radiotherapy
Model-based convolution/superposition algorithms applied to kilovoltage x-rays
Addressing the need for model-based imaging dose calculations, Alaei, et al. have gener-
ated photon energy deposition kernels for kV x-rays and commissioned a kilovoltage x-ray
unit [4–6], and later a kV-CBCT unit [3] in a radiotherapy treatment planning system.
These authors introduced two methods to account for the increased absorption of the x-
ray beam in bone. In [5] they introduced a modified CT number to density calibration
curve that artificially enhanced the density of high CT number voxels. Modifying the CT
number calibration effectively enhances Compton scattering in the high density regions of
the patient. This increases the attenuation of the beam in bone, but does not accurately
calculate the high dose regions in bone or compensate for the spectral changes of the beam
as a result of photoabsorption. With this approach average dose calculation errors of 16%
were reported, with maximum errors of up to 69% compared to measurements made with
thermoluminescent dosimeters.
In [3], model-based dose calculations were performed for a kV-CBCT imaging
procedure. In this work, dose calculation was performed with a standard CT number cali-
bration. The resulting dose errors were up to −22% for soft-tissue measurement points and
−72% in bone. To correct for the error in the bone calculation the authors retrospectively
multiplied the bone dose values by the ratio of the mass-energy absorption coefficients of
bone to water using the energy of the x-ray beam in air for reference. The corrected values
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had errors of up to almost 29%. These results overestimated the measured values since the
energy of the x-ray beam in air is less than if it had been attenuated in the body, giving a
higher ratio of mass-energy absorption coefficients. This study illustrates the main difficul-
ties in applying simple correction methods to calculate the perturbation of the model-based
calculation due to medium-dependent effects: (1) it is difficult to determine the energy
spectrum of the x-ray fluence at a given point in a patient in order to determine the proper
ratio of mass-energy absorption coefficients to use for correction of bone dose; (2) the dose
to soft tissues is affected by the reduced photon fluence resulting from photoabsorption of
the x-ray beam in bone.
The studies presented here represent the only published applications of model-
based convolution/superposition dose calculation techniques for kV energy x-rays.
Monte Carlo dosimetry for kilovoltage x-rays
The calculation of radiation dose from first principles is possible in a stochastic manner
where the probability distributions for the photon and electron interactions in medium
are used to simulate the trajectories and interactions of particles. This is the basis of
the use of Monte Carlo techniques for radiation transport in which physical quantities
are obtained statistically by averaging the contributions of a large number of simulated
particles. Several general-purpose Monte Carlo software packages have been developed
including EGSnrc [53], MCNP [20], and GEANT4 [1], of which EGSnrc has seen the most
widespread application in radiological medical physics. Using this suite, the BEAM user
code [68] was written to facilitate the simulation of medical linear accelerators, and the
DOSXYZnrc user code [78] was developed for radiation dose calculations within Cartesian
geometries, such as voxelized CT-based volumetric phantoms. These software packages have
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been used extensively for benchmarking and calculating dose from the x-ray and electron
beams from linear accelerators [27, 31, 71, 76] as well as the x-ray beams from kilovoltage x-
ray sources [11, 23, 24, 28, 33, 38, 74, 77] and are considered the gold-standard in radiation
dose calculation.
As an example of Monte Carlo kV dosimetry, Ding et al. carried out dose calcu-
lations for real patient CT-based volumetric phantoms irradiated with clinical kV-CBCT
scans used in IGRT [28, 33]. It was found that the imaging dose to soft-tissue ranged from
1–10 cGy, and that of bone from 6–29 cGy per imaging procedure.
Although the theoretical feasibility of using Monte Carlo calculations in treatment
planning systems has been previously demonstrated [9, 40, 52], these techniques have not
seen widespread clinical implementation. The computational intensity of Monte Carlo sim-
ulation has, until recently, prohibited the use of this method for the accurate calculation of
radiation dose within clinical time constraints.
Dosimetry for superficial and orthovoltage x-ray therapies
Therapeutic kilovoltage x-ray beams (called superficial or orthovoltage x-rays depending
on the energy) are used in radiation therapy for the treatment of superficial lesions. The
American Association of Physicists in Medicine (AAPM) protocol for 40–300 kV x-ray beam
dosimetry is based on an air-kerma (Kinetic Energy Released in Matter) calibration [57].
This procedure calculates the dose to the surface of a water phantom from in-air ion chamber
measuerments as
Dw,z=0 = MNKBwPstem, air
[(
µen
ρ
)w
air
]
air
, (I.4)
where M is the free-in-air ionization chamber reading for an exposure of t seconds, NK is the
chamber-specific air-kerma calibration factor determined for the beam quality, Bw corrects
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the dose for the lack of backscatter in the in-air measurement relative to the situation where
there is a water-density medium at the location of the chamber, Pstem, air is a correction
factor that accounts for scatter from the chamber stem, and [(µen/ρ)
w
air]air is the mean ratio
of mass-energy absorption coefficients of water-to-air averaged over the photon spectrum.
This measurement provides the physicist with a dose rate which is used to calculate the
length of exposure for each treatment to deliver a prescribed dose to the surface of a patient.
Knowledge of the 3D dose distribution from superficial and orthovoltage x-rays can
be obtained by measuring beam profiles and percent depth-dose curves in water [61, 69],
however, this does not take into account tissue inhomogeneities or patient specific anatomy.
Measurements have shown that the presence of a high atomic number inhomogeneity reduces
the dose to soft-tissue upstream and downstream of the inhomogeneity [21, 25, 26]. These
perturbations depend on the atomic number of the inhomogeneity, the thickness and shape
of the inhomogeneity, the the distance from the inhomogeneity, depth, and beam field-size,
making it difficult to characterize a-priori the magnitude of the effects when determining an
exposure time for superficial or orthovoltage x-ray therapy. Seuntjens and Ma [70] calculated
dose conversion factors (Dtissue/Dwater) and the effects of material on depth scaling for tissue
dose calculations for kV x-ray beams using Monte Carlo techniques. They found that for
soft-tissues the effects were small, however bone-dose conversion factors ranged from 0.3 to
1.7, and depth scaling factors varied from 1.7 to 7.7 in the energy range studied. This study
was limited due to the lack of availability of patient dose calculations based on volumetric
CT, and thus a general correction method for arbitrary geometry remained elusive.
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I.2.2 Radiation dosimetry for diagnostic CT
Dosimetry techniques used in diagnostic radiology for CT have been developed
for regulatory and quality assurance (QA) measures rather than for accurate patient spe-
cific radiation dose calculation. To this end, dosimetric specifications are geared towards
characterizing the output of CT units. Patient dosimetry from these measurements re-
quires extrapolation to patient and organ doses based on studies performed on reference
phantoms. A key difference between diagnostic radiology and radiation therapy is that the
radiation risk from diagnostic procedures is stochastic except for extraordinary cases and
the probability of radiation induced cancer mortality from low-dose exposures is assumed
to be proportional to effective dose. Therapeutic radiation, on the other hand, is delivered
to levels exceeding the thresholds for non-stochastic sequelae such as erythema, epilation,
and fibrosis. In order to minimize stochastic radiation risks it is important to ensure that
CT units in diagnostic radiology are exposing patients to minimal radiation while obtaining
diagnostically useful images. The metrics devised to evaluate dose from CT reflect this
need.
The central concept in CT dosimetry for diagnostic applications is the Computed
Tomography Dose Index (CTDI) [72] given as
CTDI =
1
T
∫ +∞
−∞
D1 (z) dz, (I.5)
where T is the thickness of a single axial slice of the CT image, and D1 (z) is the single slice
dose distribution along the axial direction of the scanner. CTDI measurements of the dose
profile are typically performed in phantom with a 100 mm cylindrical ion chamber, and
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denoted CTDI100. Phantom measurements are performed in two acrylic phantoms, a head
phantom with a 16 cm diameter and a body phantom with a 32 cm diameter. As a single
axial dose measurement does not uniquely specify the average dose to the irradiated volume,
measurements are taken at the periphery (CTDIp) and center (CTDIc) of the phantoms and
are combined to give a weighted average index:
CTDIw =
1
3
CTDIc +
2
3
CTDIp (I.6)
To account for helical CT acquisition, the quantity CTDIvol can be obtained by dividing
CTDIw by the pitch, defined as the magnitude of table motion for one revolution of the x-ray
tube around the table. Another quantity called the dose-length product (DLP) is obtained
by multiplying CTDIvol by the length of the irradiated volume, and is directly related to the
amount of radiation delivered to the patient. Commercial imaging units typically provide
the user with DLP and CTDIvol estimates for performed scans [48].
A second fundamental quantity, energy imparted (), is the integrated energy
deposited in a patient [47]:
 =
∫
ρ (r)D (r) dV, (I.7)
where ρ is the mass density and D is the dose of the irradiated volume V . For a cylindrical
phantom this can be estimated by obtaining the CTDIvol for an irradiated section and
multiplying by the mass of the irradiated section.
Monte Carlo simulations have been performed on cylindrical and anthropomorphic
phantoms to generate the ratio of effective dose to energy imparted (E/) for patients [8, 75].
These values can be multiplied by the energy imparted for a particular scan using infor-
mation obtained in a measurement phantom to obtain an estimate of total body radiation
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dose for a given procedure. Organ doses can be obtained in a similar manner by using
Monte Carlo simulation to obtain organ dose normalized to a measurable quantity, such
as the CTDIvol. These can be used in conjunction with CT unit specific measurements to
provide an estimate of organ doses for the various settings of a CT unit [49, 50]. Energy
imparted to effective dose conversion factors have been calculated by Atherton et al. [8].
In this work, the energy imparted to an anthropomorphic phantom from head, chest, and
abdominal scans was calculated. These estimates are not patient specific and do not provide
three-dimensional organ dose distributions, rather they provide estimated average doses to
organs based on generalized anthropomorphic phantoms.
Since the development of these dosimetry techniques, CT units with multiple ar-
rays of detectors have been introduced that produce radiation beams wider than the 100 mm
ion chamber used for CTDI measurements. As such, several authors have called the utility
of CTDI into question [12, 16, 36, 37, 42]. With cone-beam CT, this index is even less
appropriate as the geometry of the dose profile is not well suited for measurement by a sin-
gle cylindrical ion chamber. A new dosimetry formalism has recently been introduced that
was designed to be applicable for arbitrary CT acquisition including helical and cone-beam
irradiation [37]. The central concept of the new methodology for conventional CT is the
equilibrium dose, Deq, given by
Deq =
1
b
∫ ∞
−∞
D1
(
z′
)
dz′, (I.8)
where b is the spacing between successive scans and D1 (z) is the single axial rotation dose
profile. The equilibrium dose is similar in concept to the CTDI, however, the measurement
technique differs in that a thimble ionization chamber with an active length of 20-35 mm
is used with an extrapolation method to integrate the charge collected for the entire single
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slice dose profile.
Although the proposed new metrics are appropriate for quality assurance and
acceptance testing of the wide array of CT equipment available, they do not provide patient
specific organ dose estimates. Monte Carlo simulations could be used, as described above,
to obtain equilibrium dose to organ dose conversion factors for mathematical phantoms, but
a flexible calculation method based on individual patient anatomy is desirable, particularly
in situations such as image-guided radiotherapy where organ doses could approach non-
stochastic toxicity thresholds.
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II An algorithm to calculate the dose to water equivalent media from
kilovoltage energy x-rays
II.1 Introduction
In this chapter we develop the new model-based convolution/superposition dose
calculation algorithm for kilovoltage energy x-rays. Model-based dose calculation algo-
rithms are ubiquitous in radiation therapy treatment planning systems for megavoltage
energy x-ray dose calculations. Studies by Alaei et al. [4–6] extended the capability of the
Philips PINNACLE treatment planning system (Philips Medical Systems, Milpitas, CA)
to calculate the radiation dose to patients from kilovoltage x-rays. In a more recent study
this work was further extended to commission a kV-CBCT beam in the PINNACLE sys-
tem [3]. This approach utilizes existing calculation techniques designed for megavoltage
x-ray beams to calculate the imaging dose from kilovoltage x-rays. The characteristics of
dose deposition are, however, very different in these two energy regimes as the range of
secondary electrons is negligible for kilovoltage x-rays, as opposed to megavoltage beams
where the secondary electron range can be macroscopic. Additionally, as the fraction of
interacting photons energy lost during a single interaction is relatively small, as is the mean
path length of kV energy x-rays, photons may undergo multiple scattering processes before
exiting or imparting all of their energy to the medium.
Motivated by the unique physical aspects of dose deposition from kilovoltage x-
rays we have developed a new convolution/superposition algorithm for kV x-rays. The new
algorithm calculates the radiation dose as the sum of primary and scatter components.
Multiple approximations are implemented to simplify the scatter dose calculation; namely,
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we introduce a simple, empirically parameterized monoenergetic scatter dose kernel, ac-
count for density inhomogeneities using a simplified global inhomogeneity correction, and
ignore kernel tilting. These approximations allow for efficient calculation of the scatter dose
convolution with the fast Fourier transform.
II.2 Methods
Model-based dose-to-water calculation
The dose to water is calculated by separately considering the dose deposited by
primary and scattered photons:
Dw = Dp +Ds. (II.1)
Since the range of electrons released by the interaction of a primary photon is negligibly
small, the primary dose is equivalent to the collision kerma:
Dp (r) = Kc (r) =
∫
φp,E (r) ·
(
µen,E (r)
ρ (r)
)
dE, (II.2)
where φp,E is the primary energy fluence, µen is the energy absorption coefficient, and
ρ is the density of the absorbing medium. The subscript E indicates that each term in
Equation II.2 is a function of energy. For polyenergetic clinical x-ray beams a typical
approach is to discretize the energy spectrum and separately calculate the quantities in
Equation II.2 for each energy bin. A key simplification in this work, however, is to treat
the x-ray beam as if it were monoenergetic. As such, the primary dose can be written as
Dp (r) = cp · φp (r) (II.3)
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where φp is the primary photon fluence, and cp is a beam-specific primary fluence to dose
conversion factor. cp is obtained in this work by empirically fitting to Monte Carlo generated
gold standard dose distributions. The primary fluence is obtained by propagating the
incident photon fluence from an x-ray beam through the patient using the ray-tracing
algorithm introduced by Siddon [73].
The dose from scattered photons is obtained by convolution/superposition of the
primary photon fluence with a dose deposition kernel:
Ds (r) = cs
∫
φ
(
r′
)
ρ
(
r′
)
k
(
r − r′) dr′, (II.4)
where cs is a beam-specific scatter dose conversion factor. The monoenergetic approximation
is again used for the scatter component of the calculation. The kernel used in this work
was parameterized as
k (r, θ) =
1− 
1−  cos θ
Ae−aρr −Be−bρr
r2
, (II.5)
where , the eccentricity, specifies the degree of forward peaking of the kernel, and θ is the
angle between the incident primary photon velocity and the vector from the interaction
point to a calculation point. The radial dependence of the kernel is motivated by the
kernel used by Ahnesjo¨ for megavoltage beams [2], and later extended by Carlsson and
Ahnesjo¨ to kilovoltage x-rays emitted from brachytherapy sources [22]. The parameters in
Equations II.3, II.4, and II.5 were obtained by empirically fitting dose calculations to Monte
Carlo generated dose distributions for simple geometric phantoms.
Density inhomogeneities are accounted for in the scatter dose calculation by scaling
the distances in the exponential terms of the scatter kernel by an average density weighted
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by the primary fluence distribution:
ρ =
∑
i,j,k ρ (i, j, k) · φp (i, j, k)∑
i,j,k φp (i, j, k)
. (II.6)
The weighted average density is calculated for each incident beam and scaled kernels are
implemented separately for each beam. This approach to density correction is motivated by
the prevalence of multiple scattering at kV energies which contributes to scattered photons
sampling a potentially large area of the patient volume prior to depositing all of their energy
in the medium or exiting the patient completely.
A further simplification of the scatter dose calculation is that we ignore the effects
of divergence on the directionality of the scatter dose kernel. This amounts to defining
the angle θ in Equation II.5 for all points as the angle that the line from the interaction
point to the calculation point makes relative to the direction of incidence of the primary
x-rays along the central axis of the x-ray beam. Figure II.1 shows a schematic depicting
this approximation, which is referred to as neglecting kernel tilting.
By neglecting kernel tilting and accounting for density inhomogeneities in a global
manner, i.e., scaling the distances in the dose deposition kernel with a single effective density
for all points in the calculation volume, the scatter dose kernel becomes spatially invariant.
This allows for the integral in Equation II.4 to be performed efficiently with the fast Fourier
transform.
Monte Carlo calculation
Monte Carlo calculations were used to obtain the incident primary fluence pro-
files for several clinically relevant x-ray beams used for kV-CBCT, and gold standard dose
distributions for simplified geometric phantoms irradiated by these beams. These distri-
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dose deposition kernels 
primary x-rays 
(a) Schematic depiction of a point kernel based dose calculation with tilted ker-
nels.
x-ray source 
primary x-rays 
dose deposition kernels 
(b) Schematic depiction of a point kernel based dose calculation with non-tilted
kernels.
Figure II.1: Kernel tilting is the process of accounting for divergence of the radiation beam
by aligning the dose deposition kernel with the incident primary x-rays. This results in a
spacially varying dose deposition kernel as shown in (a). By ignoring kernel tilting, (b),
the directionality of the dose deposition kernels is assumed to be parallel to the direction
of incidence of the primary photons at the central axis of the x-ray beam.
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butions were used to empirically determine the model parameter values for the convolu-
tion/superposition dose-to-water calculation. Model parameters were obtained separately
for each x-ray beam used. To test the resulting models we used Monte Carlo simulations to
calculate the dose-to-water and dose-to-medium distributions for multiple real patient CT
data sets with imaging sites including the head-and-neck (H&N), pelvis, and thorax. These
results are presented in Chapter IV.
The Monte Carlo calculations in this study were performed as described by Ding
et al. [28–30, 32, 34]. The x-ray beams were simulated using the BEAMnrc code [68], and
dose calculations were performed with the DOSXYZnrc usercode [53, 78]. Dose-to-water
calculations were performed by setting all materials in the calculation volume to water and
scaling the density of each voxel according to a CT number to density calibration curve.
The simulated x-ray beams were from the Varian on-board imager (OBI) system
integrated into a TrilogyTMlinear accelerator (Varian Medical Systems, Palo Alto, CA).
Figure II.2 shows an example of the TrilogyTMsystem and the orientation of the imaging
x-ray apparatus relative to the treatment head and patient positioning table. The acqui-
sition techniques used were the Varian OBI version 1.4 kV-CBCT x-ray beams denoted as
standard-dose head, pelvis, and low-dose thorax, which were described by Ding et al [34].
Each of the kV-CBCT acquisition modes makes use of a bowtie filter. Bowtie filters are ex-
trinsic filters placed on the x-ray tube to compensate for the shape of a patient. The bowtie
filter is designed so that the thicker parts of the filter attenuate the x-ray beam that will
irradiate thinner parts of a patient. The purpose of the filter is to ensure that a relatively
uniform photon fluence irradiates the detector. The standard-dose head technique uses the
full bowtie filter shown in Figure II.3, while the pelvis and low-dose thorax techniques use
the half bowtie filter in Figure II.3. The x-ray energies for these kV-CBCT x-ray beams are
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Figure II.2: Varian Trilogy with on-board imaging. The x-ray tube and detector are
mounted at 90◦ from the treatment head and are only extended during kV imaging or
CBCT procedures. This set-up enables acquisition of kV images or CT scans while the
patient is in the treatment position immediately prior to treatment. (Reproduced from [32]
with permission)
Figure II.3: Half and full bowtie filters placed in front of the x-ray source for kV-CBCT
acquisition. (Reproduced from [32] with permission)
100 kVp for the head technique, 110 kVp for the thorax, and 125 kVp for the pelvis.
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II.3 Results
The incident primary fluence profiles were obtained by simulating the x-ray beams
used in this study using the techniques described above. The monoenegetic depth depen-
dence of the fluence was empirically obtained by simulating the x-ray beams interacting
with a phantom consisting of a narrow column of water, allowing for scattered photons to
exit the phantom. This simulation was performed for x-rays along the central axis of the
x-ray beam, thus neglected the effect of lateral energy differences on the depth dependence
of the primary fluence. Figure II.4 shows fluence profiles for the pelvis, standard-dose head,
and low-dose thorax x-ray beams used in this study. The shape of the fluence profile along
the anode-cathode axis (X) is significantly affected by the bowtie filter used in the x-ray
mode. The fluence is relatively constant in the patient superior-inferior direction (Z) as the
bowtie filter is of constant thickness along this direction.
Figure II.5 shows the depth dependence of the photon fluence calculated for a
phantom consisting of a narrow column of water placed 100 cm from the x-ray source. The
narrow phantom ensures that scattered photons leave the calculation phantom and are thus
not accounted for in the primary fluence profile. Density inhomogeneities are accounted
for in the primary dose calculation by using the radiological depth to calculate the primary
fluence in Equation II.3.
Dose calculations were performed for each x-ray beam with three simple, cubic wa-
ter phantoms with dimensions of 10 cm per side, 20 cm per side, and 30 cm per side. A single
incident x-ray beam normal to a surface of the cube was simulated for each configuration
of beam type and phantom. These dose calculations were used to find model parameters
for each beam by fitting the model-based calculation to the Monte Carlo results.
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Figure II.4: Fluence profiles for the standard-dose head, pelvis, low-dose thorax, and pelvis
spot light kV-CBCT x-ray beams taken at 100 cm from the x-ray source. (Reproduced
from [29] with permission)
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Figure II.5: The depth profile of the photon fluence simulated for a phantom consisting of
a narrow water column placed 100 cm from the x-ray source.
We found that we could use the same kernel parameters for each x-ray beam,
but adjust the ratio of the scatter dose conversion factor to the primary dose conversion
factor (cs/cp) to fit each beam. Optimal values of this ratio were found to be 0.0081 for
the pelvis technique, 0.0071 for the low-dose thorax, and 0.0059 for the standard-dose head.
The kernel parameters resulting from the model-fitting procedural calculations are shown in
Table II.1. Figure II.6 shows the radial dependence of the scatter dose kernel. The inverse
square law has been removed from these plots by multiplying the kernel by r2. The inverse
square independent scatter kernel increases within a 5 cm radius as a result of using two
exponential terms to parameterize the kernel in order to accurately model multiply scattered
photons [22]. The inverse square law dominates the growth from multiple scatter, however,
resulting in a monotonically decreasing function when this effect is taken into account.
Figure II.7 shows an example calculation using these model parameters to calculate
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Table II.1: Model parameters for the empirical scatter dose kernel.
Parameter Value
 0.5000
A 0.1194
a 0.1040
B 0.1037
b 0.3158
0 5 10 15 20
r [cm]
0.00
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0.02
0.03
0.04
0.05
0.06
r2
k
( θ
,r
)
θ=0
θ=pi/4
θ=pi/2
θ=3pi/4
θ=pi
Figure II.6: Radial dependence of the scatter dose kernel for various angles from the direc-
tion of the incident photon to the voxel being calculated. The inverse square component of
the kernel has been removed by multiplying the kernel by r2.
the dose from the pelvis x-ray beam incident on the 30cm × 30cm × 30cm water phantom
from above. The model calculation agrees well with the Monte Carlo calculation for this
situation.
Figure II.8 shows example results for calculations performed using the standard-
dose head x-ray beam incident on the 20cm × 20cm × 20cm phantom. Excellent agreement
is found for the head x-ray technique as with the pelvis x-ray beam. The low-dose thorax
x-ray beam is very similar to the pelvis x-ray beam so results for this technique are not
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(a) Monte Carlo calculation dose-to-water distribu-
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(b) Model-based calculation dose-to-water distribu-
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(c) Depth dose profiles
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(d) Off-axis dose profiles
Figure II.7: Dose planes and profiles for calculations performed on a 30cm × 30cm × 30cm
water phantom with the pelvis x-ray beam incident from above.
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shown.
Figure II.9 shows the results of dose calculations performed with the pelvis x-
ray beam irradiating the three different size water phantoms. Relative dose is presented
with the dose for all calculations normalized to the maximum dose to the 30cm phantom
as calculated by Monte Carlo. The difference in magnitude of the doses to each of the
three phantoms is due to two factors: (1) all calculations were done with the center of
the phantom placed 100cm from the radiation source so the dose at the surface for each
calculation is scaled by the inverse of the square of the source-to-surface distance; (2) the
larger phantoms result in an increase in the scatter dose as a larger volume is irradiated by
the primary photon fluence and more energy is imparted to the phantom.
Figure II.9 illustrates a difficulty of applying model-based convolution/superposition
algorithms to phantoms of varying sizes; namely that scatter kernels derived for scatter-
ing conditions present in a given volume phantom may overestimate or underestimate the
scatter dose for calculations performed in smaller or larger volumes respectively. This is
partially explained by the prevalence of multiple-scattering events which cause scattered
photons to rescatter within the phantom and continue to deposit dose in the vicinity of
the original interaction point. If a smaller phantom is used to derive a scatter kernel ap-
plied to calculations within a larger volume, then scattered photons that may have multiply
scattered within the larger phantom do not contribute to the calculated scatter dose and
the dose will be underestimated. Conversely, if a large phantom is used to derive a scatter
kernel that is subsequentally applied to dose calculation in a small phantom, then photons
that would have exited the small phantom without contributing to the scatter dose are
now included in the calculation. This problem has been previously noted, and it has been
recognized that scatter kernel generation in phantoms of comparable size to the dose cal-
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(a) Depth dose profiles for the standard-dose head x-ray beam
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(b) Off-axis dose profiles for the standard-dose head x-ray beam
Figure II.8: Depth-dose curves and dose profiles for calculations performed on the 20cm
water phantom irradiated by the standard dose head x-ray beam.
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(a) Depth dose profiles for the pelvis x-ray beam irradiating each of the three simple cubic
water phantoms
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(b) Off-axis dose profiles at 5 cm depth for the pelvis x-ray beam irradiating each of the
three simple cubic water phantoms
Figure II.9: Dose profiles for calculations performed on the 10cm, 20cm, and 30cm water
phantoms irradiated by the pelvis x-ray beam from above.
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culation volume may be advantageous [22]. We adopted this approach by determining the
scatter kernel parameters that led to agreement between the model calculation and Monte
Carlo calculations for the 20 cm phantom and the 30 cm phantom. As shown in Figure II.9,
we were able to obtain accurate results for both of these phantoms using the same kernel
parameters. This is at the expense of accuracy for the 10 cm phantom, which shows an
overestimation of the dose at depth using our model. Our choice is justified, however, in that
most clinical situations of significance involve the irradiation of volumes with dimensions
generally greater than 10 cm.
Figure II.10 shows results of dose calculations performed with the pelvis x-ray
beam incident on the 30cm phantom from an oblique angle. In these calculations the x-ray
beam is diagonally incident on the phantom from the top right corner. Like the normally
incident beam, the oblique x-ray beam results in high-dose areas at the surface of the
phantom. The model-based calculation slightly overestimates the dose at the surface of the
phantom due to overestimating the scatter dose in these regions. The explanation for this is
similar to that for the 10 cm water phantom results shown in Figure II.9 as the model-based
calculation assumes that there are full scatter conditions in the calculation volume, even if
they do not exist. In this case, the oblique incidence increases the water-air interface which
in turn reduces the contribution from laterally scattered photons to the scatter dose. The
model-based calculation does not fully account for the lack of lateral scatter as the scatter
dose deposition kernel implicitly assumes full scatter conditions.
To show the effects of low-density inhomogeneities on the dose calculation model
similar calculations were performed for a second 30cm × 30cm × 30cm water phantom
with a 10cm × 20cm × 20cm lung-density insert, as shown in Figure II.11. Calculations
were performed for an x-ray beam incident normal to the surface from above the phantom.
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(a) Monte Carlo dose plane
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(b) Model-based dose plane
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(c) Depth-dose profile along the diagonal
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(d) Off-axis profiles at varying depths
Figure II.10: Dose calculations performed for the 30cm water phantom irradiated obliquely
by the pelvis x-ray beam. The beam is incident from the top right corner of the phantom.
Monte Carlo (solid) and Model-based (dashed) dose profiles are shown along the central axis
of the beam (bottom left) and along lines perpendicular to the central axis of the incident
x-ray beam for various depths (bottom right).
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The dose calculation results shown in Figure II.11 are for the pelvis x-ray beam. The
model-based calculation used the scaled kernel method with a calculated effective density
scaling factor of 0.72. Good agreement is seen between the dose calculations both in the
lung-density, and in the water-density portions of the calculation volume.
Figure II.12 compares these results to those obtained using the model-based cal-
culation without kernel scaling, i.e., setting ρ = 1. The depth-dose curve shows that the
effect of scaling the kernel is to enhance the dose in the low-density region, whereas the
dose to the water-density region is not significantly affected by scaling the kernel. Note that
both calculations overestimate the dose in the water density region immediately upstream
of the first water-to-lung interface. This is due to the model incorrectly modeling the lack
of backscattered photons from interactions in the lung-density material.
The inhomogeneity correction method employed in this work differs from typi-
cal approaches employed in radiotherapy treatment planning systems using a point-kernel
convolution. For example, the most common of these approaches, the collapsed-cone al-
gorithm [2], scales the dose deposition kernel separately along rays emanating from an
interaction point according to the densities of voxels along each ray. This approach as-
sumes that scattered photons transfer energy to the absorbing medium rectilinearly from
their point of origination until all of their energy is deposited in the medium.
As this approach is successfully implemented in commercial radiotherapy treat-
ment planning systems, we seeked to compare results obtained using a similar calculation
to results obtained using our scaled kernel method. To accomplish this comparison we
developed a second scatter dose convolution algorithm that, similar to the collapsed cone
method, scales the scatter kernel along rays emanating from an interaction point according
to the densities that each ray intersects.
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(a) Water calculation phantom with lung density insert
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Figure II.11: Results for calculations performed for the Standard-Dose Pelvis x-ray beam
incident from above on a 30cm×30cm×30cm water phantom with a 10cm×20cm×20cm
lung density insert. The scaled kernel method was used for this calculation, with a kernel
scaling factor of 0.72.
38
20 40 60 80 100 120 140
depth [voxel]
0
20
40
60
80
100
re
la
ti
v
e
 d
o
se
 [
%
]
Monte Carlo
Model: ρ¯=1.00
Model: ρ¯=0.72
Figure II.12: Comparison of depth-dose curves between the model-based calculation with
the effective density, ρ, set to 0.72 as shown in Figure II.11, and with the effective density
set to unity to show the effects of neglecting the inhomogeneity in the scatter kernel. Cal-
culations were done on the same phantom as shown in Figure II.11. Voxels are of dimension
0.25 cm in each direction.
The basis of this calculation, like our scaled kernel method, is to first propagate
the primary fluence through the patient using the densities of the patient to attenuate the
beam. Once the primary fluence is known, the convolution in Equation II.4 is calculated
by explicit summation:
Ds (l,m, n) = cs
∑
i,j,k
φ (i, j, k) ρ (i, j, k) k (RPLi,j,k→l,m,n) , (II.7)
where RPLi,j,k→l,m,n is the radiological path length from voxel (i, j, k) to voxel (l,m, n). A
simplification made in our implementation of this algorithm was to only evaluate RPL along
a finite number of rays emanating from an interaction point. This was done by defining rays
using sets of discrete polar and azimuthal coordinates (θi, ϕi) defined relative to the vector
from the radiation source to the interaction point. Ray tracing was then performed along
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each ray to obtain tables of RPL versus physical path length L for each ray. To obtain the
RPL for an arbitrary voxel (l,m, n) at a position not along one of these rays, the physical
distance between that voxel and the interaction point is calculated:
L = d ·
√
(i− l)2 + (j −m)2 + (k − n)2, (II.8)
where d is the dimension of the isotropic voxel, and the table of RPL versus L for the ray
closest to voxel (l,m, n) is used to look up the value of RPL.
This algorithm was slow to implement in practice as the number of operations
required for a calculation volume of dimension N3 is of the order of N6. This is in contrast
with the fast Fourier transform in which the number of operations is proportional to (2N)3 ·
ln 2N [2]. This limited calculation using this approach to just a few simple cases. We first
showed that we could duplicate the results seen in Figure II.7 with this approach as the
two models should yield identical results for a homogeneous water phantom since the same
scatter kernel was used for each calculation. Upon validation, we tested the approach for
inhomogeneity correction by performing calculations on the phantom seen in Figure II.11
for the same situation in which a single x-ray beam is incident from above. Figure II.13
shows these results and how they compare to Monte Carlo and the scaled kernel method. In
these graphs, the black lines are the Monte Carlo calculation, the red lines are the scaled-
kernel method using a kernel scaling factor of 0.72, and the green lines are the results for the
second kernel-based method with density scaling along rays emanating from the interaction
point. The scaled kernel method is shown to be only slightly less accurate than the method
in which scaling is done for rays originating from the interaction point. In light of the
significant difference in calculation time we feel that the slight loss in accuracy in using the
scaled kernel method is acceptable.
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Figure II.13: Comparison of the scaled kernel method (red) vs. an inhomogeneity corrected
model-based dose calculation where density scaling is performed along rays emanating from
each interaction point (green). The phantom used for calculation is the same as shown in
Figure II.11. Voxels are of dimension 0.25 cm in each direction.
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II.4 Discussion and conclusions
We have presented a new model-based convolution/superposition dose calculation
algorithm for kilovoltage energy x-rays and have employed the algorithm to calculate the
dose-to-water for simple geometric phantoms from kV x-rays. The new technique employs
multiple simplifications to exploit the physical characteristics of x-ray interactions at the
kilovoltage energy range: 1) the x-ray beam is approximated as monoenergetic; 2) ker-
nel tilting is ignored; 3) density inhomogeneities are accounted for in a global manner by
scaling the scatter kernel for each individual beam by an average patient density. The
monoenergetic approximation eliminates the need for multiple scatter dose convolutions
to be performed for different energy bins, while the use of an invariable kernel for each
beam enables the scatter dose convolutions to be performed with a fast Fourier transform.
While these approximations may introduce additional error in the dose calculation relative
to a more sophisticated algorithm, we found the dose calculations to be within acceptable
accuracy for the simple phantom calculations performed in this chapter. The results of
dose-to-water calculations for real patients irradiated with kV x-rays will be presented in
chapter IV.
In the following chapter we develop the methods to determine medium-dependent
correction factors for patient-specific and procedure-specific dose calculations for kilovoltage
x-rays. The correction method will be used in conjunction with the model-based dose-to-
water calculation developed here to calculate dose-to-medium distributions for real patients.
These results will be presented in chapter IV.
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III Methods to account for medium-dependent effects in kilovoltage
energy x-ray dose calculations
III.1 The direct approach to medium-dependent correction
III.1.1 Introduction
In the previous chapter we developed a new model-based dose calculation algo-
rithm for kilovoltage x-rays. Model-based dose calculations, however, have known deficien-
cies for kV x-rays in regions in or near bony anatomy since photoabsorption in bone leads
to large differences between dose-to-medium and dose-to-water [5, 6, 33, 35]. To account
for medium-dependent effects, Alaei et al. used a simple correction method based on mul-
tiplying the dose to bone voxels by the ratio of the bone-to-water mass-energy absorption
coefficients [3]. This method was shown to be inaccurate as it is difficult to characterize a
priori the energy spectrum at a given voxel for complicated geometries, such as volumes
based on patient CT data. Furthermore, this method fails to correct the dose to soft tissues
in the vicinity of bone that are irradiated by a reduced fluence relative to the model-based
dose-to-water calculation.
To overcome the deficiencies of model-based calculations for kilovoltage dose cal-
culation, an empirical correction based algorithm, the medium-dependent correction–direct-
approach (MDC-DA), is developed [35]. This algorithm considers both medium-dependent
effects and electron density effects by applying a correction factor matrix that accounts for
the effects of photoabsorption in bone on the dose distribution obtained using a model-based
dose calculation. The correction factor matrix is obtained by use of an empirical param-
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eterization of the medium-dependent correction factors. In this section we introduce this
method and validate the accuracy of the MDC-DA to calculate the radiation dose delivered
to patients imaged with kV-CBCT for alignment prior to radiotherapy by comparing dose
distributions calculated with the MDC-DA to Monte Carlo calculations.
III.1.2 Methods
Algorithm overview
The MDC-DA algorithm calculates the dose-to-medium by applying a correction factor,
MDC (x, y, z), to a dose-to-water matrix:
Dmedium (x, y, z) = MDC (x, y, z)×Dwater (x, y, z) . (III.1)
The dose-to-water calculation may be performed using a model-based method or by Monte
Carlo simulation in which all media is set to water with density scaled to that of the actual
media.
The matrix MDC (x, y, z) is obtained by considering sets of parallel rays, called
correction fields, incident on the patient from a discrete set of angles, θi, about the imaging
isocenter. The distribution of incident correction fields depends on the geometry of the
image acquisition. For example, the kV-CBCT x-ray beams simulated in this work irradiate
the patient in either a half-fan mode, or a full-fan mode. The half-fan acquisition technique
is used to image larger volumes. This is done by irradiating roughly half of the patient at
a time, covering the entire patient by making a full 360◦ rotation with the x-ray source in
order to reconstruct the full volume. The full-fan acquisition technique is used for smaller
volumes such as a head. For this technique, the entire volume is irradiated by the x-ray
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Patient
(a) Half-Fan
Patient
(b) Full-Fan
Figure III.1: The rotation of the x-ray source around the patient during tomographic imag-
ing is modeled by applying sets of one-dimensional correction factors along rays incident on
the patient from a finite number of angles. Half-fan beams were modeled with eight sets of
incident rays evenly spaced and spanning 360◦ . Full-fan beams were modeled with six sets
of incident rays of one-dimensional correction factors spanning 200◦ .
beam and a 200◦ rotation of the source is used. Figure III.1 illustrates the discretization of
x-ray beams for correction factor calculations for these techniques.
The effects of bone on the dose distribution are accounted for by applying an
empirically parameterized one-dimensional correction factor along each ray. The param-
eterization is based on the distribution of bone and soft-tissue that each ray intersects.
In this manner, each correction field provides the medium-dependent correction factor for
an x-ray beam irradiating the patient from the angle of incidence of the correction field.
The total correction factor at a voxel is taken to be a weighted average of the individual
contributions to that voxel from each correction field.
For each ray, which for notational convenience we will take to be incident along
the x-direction for a given y, z, and θi, the correction factor, MDC (x, y, z; θi), is obtained
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as
MDC (x, y, z; θi) =
∏
j
αj (x, y, z; θi)× βj (x, y, z; θi)× γj (x, y, z; θi) (III.2)
where α, β, and γ correct for the upstream, in-bone, and downstream effects of bone on
the dose distribution respectively. The product in Equation III.2 is over each bone that the
ray intersects, bounded by x1j (y, z; θi) upstream and x
2
j (y, z; θi) downstream.
This parameterization was motivated by studying the medium-dependent correc-
tion factors for kV x-ray beams incident on simple slab-geometry virtual phantoms. For
example, Figure III.2 shows the correction factor along the central axis of a kV-CBCT
beam incident on a simple water phantom with a 2 cm slab of bone. The correction factors
were obtained using Monte Carlo simulations in which dose-to-medium and dose-to-water
were calculated separately for this beam interacting with the phantom. The multiplicative
correction factor needed to convert the dose-to-water to dose-to-medium is then the ratio
MDC (x, y, z) =
Dmedium (x, y, z)
Dwater (x, y, z)
. (III.3)
The x-ray beam is incident from the left, and is traveling left to right in this
graph. The blue and white sections below the graph depict the distribution of water and
bone in the phantom, respectively. There are three distinct regions in the correction factor
distribution–upstream, in-bone, and downstream–with the in-bone region evidenced by the
large (>2) correction factors resulting from increased photoabsorption in bone relative to
water.
The upstream correction accounts for the decrease in the backscattered photon
fluence at points upstream of bone due to increased absorption of these photons in bone
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Figure III.2: Medium-dependent correction factor as a function of depth along the central
axis of a kV-CBCT beam incident on a simple water phantom with a 2 cm slab of bone at
5 cm depth. The x-ray beam is incident from the left of the phantom.
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relative to water. This effect can be parameterized as:
αj (x, y, z; θi) =

α∞ − (α∞ − α0) e−µα(x1j−x) , x < x1j
1 , otherwise
(III.4)
Here, α0 is the correction factor in soft tissue at the bone-tissue interface, and α∞ is the
correction factor far upstream from the interface. α∞ should be close to, but less than
unity in order to account for the slightly smaller fluence at these locations. The parameter
µα models the rate at which the up-stream medium-dependent correction approaches the
asymptotic value with increasing up-stream distance from the bone-tissue interface.
The factor βi is the in-medium correction factor that accounts for the increased
dose to bone due to photoabsorption in bone. This effect can be modeled with the following
parameterization:
βj (x, y, z; θi) =

β1e
−µ1(x−x1j) + β2e−µ2(x
2
j−x) , x1j ≤ x ≤ x2j
1 , otherwise
(III.5)
Here, the photon fluence is modeled to have two components, a primary fluence (subscript
1), and a backscattered fluence (subscript 2). The parameters β1 and β2 are the medium-
dependent correction factors applicable on the bone side of the bone-tissue interface for
the primary and backscattered photons, respectively, and the exponential factors account
for the differential attenuation of the low-energy x-rays in bone relative to water. From
Equation I.1, we can see that the value of β1 and β2 should be close to the ratio of the
mass-energy absorption coefficient of bone to that of water evaluated at the primary and
back-scattered photon energies respectively. However, it is difficult to determine the photon
energy spectrum at a particular location within a patient without Monte Carlo simulation
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so we relied on empirical studies to determine values for these parameters.
The downstream correction factor, γj , accounts for the reduction in the down-
stream photon fluence due to photoabsorption in bone. We found that an identical param-
eterization to the upstream correction can be used:
γj (x, y, z; θi) =

γ∞ − (γ∞ − γ0) e−µγ(x−x2j) , x > x2j
1 , otherwise
(III.6)
The downstream model parameters thus have similar interpretations to the analogous up-
stream parameters.
Monte Carlo simulation and MDC-DA model parameters
Monte Carlo techniques were used to derive the empirical MDC-DA model parameters
used for calculation, and to provide gold-standard dose distributions to benchmark the
accuracy of the MDC-DA using these parameters. The kV-CBCT beams simulated for dose
calculation in this study were from the Varian on-board imager (OBI) system integrated into
a TrilogyTMlinear accelerator (Varian Medical Systems, Palo Alto, CA). The beams used
were the OBI version 1.3 half-fan beam operated with a half bow-tie filter, and characterized
in [32]; and the OBI version 1.4 Standard Dose Head, Pelvis, and Low-Dose Thorax beams
described in references [30, 34]. The x-ray beams were simulated using BEAMnrc [68]. The
Standard Dose Head acquisition technique uses the full bow-tie filter whereas the Pelvis
and Low-Dose Thorax techniques were simulated with the half bow-tie filter. The Standard
Dose Head acquisition uses a 200◦ rotation of the x-ray source that is posteriorly incident
on a supine patient. Table III.1 lists the kV-CBCT scan acquisition techniques used for
each patient in this study.
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Table III.1: kV-CBCT acquisition techniques used for dose calculation for each patient in
this study. Each kV-CBCT x-ray beam simulated was from Varian’s OBI system.
Patient CBCT acquisition technique X-ray Voltage (kVp)
Adult H&N 1a OBI 1.3 125
Adult H&N 2 OBI 1.4 standard-dose head 100
Adult H&N 3 OBI 1.4 standard-dose head 100
Adult H&N 4 OBI 1.4 standard-dose head 100
Pediatric H&N 1a OBI 1.3, OBI 1.4 Standard Head 125
Adult pelvis 1a OBI 1.3 125
Adult pelvis 2 OBI 1.4 pelvis 125
Adult pelvis 3 OBI 1.4 pelvis 125
Adult chesta OBI 1.3 125
Adult chest OBI 1.4 low-dose thorax 110
Adult chest OBI 1.4 low-dose thorax 110
Adult chest OBI 1.4 low-dose thorax 110
Adult legs OBI 1.4 pelvis 125
Pediatric abdomen OBI 1.4 low-dose thorax 110
a Patients used to derive correction factor curves.
Patient dose-to-medium distributions were calculated with the Monte Carlo user
code DOSXYZnrc [53, 78]. CT-based volumetric phantoms were created for each patient
using four materials: air, lung, soft-tissue, and bone. Material segmentation was performed
using a CT number to density calibration curve. In addition to the dose-to-medium dis-
tributions, the dose to water-like media was obtained with Monte Carlo calculation for
each patient by setting each voxel in the CT-based volumetric phantoms to water, but
with density assigned according to the CT number to density calibration. This second cal-
culation is consistent with the model-based convolution/superposition treatment planning
system calculations of Alaei et al. [3] that account for density inhomogeneities, but neglect
medium-dependent effects.
The MDC-DA makes use of 10 tunable model parameters that characterize the
effects of bone on the dose distribution resulting from kilovoltage x-rays [35]. In this work,
we obtained independent model parameter sets for kV-CBCT imaging procedures performed
on four patients with imaging sites including the adult head-and-neck (H&N) , pediatric
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H&N, chest, and pelvis. The patients used for this purpose are referred to as Adult H&N
1, Pediatric H&N: OBI 1.3, Adult Pelvis 1, and Adult Chest 1. Separate parameter sets
were determined for each patient by iteratively calculating and comparing the correction
factors obtained using the MDC-DA correction method to gold-standard correction factors
obtained by taking the ratio of the patient dose-to-medium distribution to the dose-to-water
distribution calculated with the Monte Carlo technique. The MDC-DA calculations used to
derive these model parameters utilized 8 sets of incident rays of one-dimensional correction
factors separated by 45◦ (Figure III.1). An average model parameter set was obtained
from the four individually obtained parameter sets, which was used for subsequent dose
calculations throughout this work.
Benchmark calculations
To benchmark the accuracy of the MDC-DA algorithm, dose calculations were performed
with the algorithm for 14 patients; four patients were used to derive the MDC-DA model
parameters, and 10 patients were used as test cases for these parameter sets. These 10 pa-
tients in the second group had imaging sites including the head-and-neck, chest, abdomen,
pelvis, and legs. Dose calculations were performed by applying the correction factors ob-
tained with the MDC-DA to the dose-to-water distributions obtained as described above.
These calculations were carried out for each patient using an average model parameter set
obtained from the derived parameter sets. The accuracy of these calculations was assessed
by comparing the resulting dose distributions to Monte Carlo calculated dose distributions.
In addition, we compared our results to a simple correction method based on
multiplying the dose-to-water values calculated for bone voxels by the free-in-air, bone-to-
water mass-energy absorption coefficient ratio using the procedure proposed by Alaei et
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Table III.2: MDC-DA model parameters obtained for the patient types and imaging sites
used in this study. The average parameter set was determined by taking the average of each
parameter from the four patients.
Parameter Adult H&N 1 Pediatric H&N 1 Pelvis 1 Chest 1 Average Set
α∞ 0.96 0.98 0.99 0.99 0.98
α0 0.86 0.85 0.83 0.85 0.85
µα 0.82 0.82 0.85 0.85 0.84
β1 2.24 2.21 2.28 2.23 2.24
µ1 0.22 0.20 0.17 0.15 0.19
β2 1.33 1.33 1.33 1.33 1.33
µ2 0.17 0.16 0.18 0.16 0.17
γ∞ 0.95 0.95 0.95 0.95 0.95
γ0 0.72 0.83 0.77 0.78 0.78
µγ 0.19 0.19 0.19 0.19 0.19
al. [3]. The energy of the unattenuated x-ray beam was used to determine the mass-energy
absorption coefficient ratio.
III.1.3 Results
MDC-DA model parameters
Table III.2 lists the MDC-DA model parameters obtained for dose calculations for patients
Adult H&N 1, Pediatric H&N: OBI 1.3, Adult Pelvis 1, and Adult Chest 1, and the model
parameter set obtained by taking the average of the MDC-DA parameters for each imaging
site. It is evident that there is some variation in the optimal parameters generated for
different patient anatomies. This is a result of the difference in the relative amount of bone
and soft-tissues in each imaged site, and of the arrangement of bone and soft-tissues in
each site affecting the average energy fluence distribution within each patient. The average
parameter set was used for the presented calculations in this study.
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Benchmark results
Figure III.3 shows axial dose distributions in colorwash, and line profiles calculated for
a pediatric H&N patient scanned with the OBI 1.4 Standard Dose Head protocol with a
200◦ posterior source rotation. Dose calculations were performed using four techniques:
the Monte Carlo technique, the density-corrected-only dose-to-water technique, the simple
correction method using the bone-to-water mass-energy absorption coefficient ratio, and
the MDC-DA method. The distributions are each normalized to the maximum dose to the
irradiated volume calculated with Monte Carlo. The Monte Carlo dose distribution shows
a significant increase in the dose to the skull relative to the adjacent soft-tissue, which is
due to the increased photoabsorption of the x-ray beam in bone. The density-corrected-
only dose-to-water calculation resulted in a relatively homogeneous dose distribution in
which the dose to bone was nearly equivalent to the dose to the adjacent soft-tissue. The
simple correction method assumes a constant dose correction factor for all bone voxels and
significantly overestimates the dose to bone everywhere. The MDC-DA algorithm corrected
the bone dose to include the contribution from photoabsorption, and corrected the soft-
tissue dose to account for the reduced x-ray fluence at these voxels due to photoabsorption.
It is seen that the dose varies significantly along the patients anterior-posterior axis. This
is due to the posterior scanning technique, which was accounted for with the MDC-DA
by applying only correction factors calculated along the posteriorly incident rays shown in
Figure III.1 (right).
Figure III.4 shows dose planes and profiles for the abdominal kV-CBCT scan of a
prone pediatric patient. The dose delivered to the vertebrae and ribs is roughly a factor of
three greater than the dose to surrounding soft-tissues. The profile along line segment AB
shows that the dose-to-water calculation overestimates the dose to the soft-tissue in regions
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Figure III.3: (Top) Axial slice and corresponding dose planes for a pediatric H&N kV-
CBCT scan. The acquisition technique simulated was the OBI 1.4 Standard Dose Head
with a 200◦ posterior rotation. Doses were calculated with the Monte Carlo technique,
the density-corrected-only dose-to-water, the simple correction based on the bone-to-water
mass-energy absorption coefficient ratio, and the MDC-DA. (Bottom) Dose profiles through
the horizontal and vertical lines shown in the CT image (top left). The dose distributions
here are normalized to the maximum dose to the irradiated volume calculated with Monte
Carlo.
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Figure III.4: (Top) Axial slice and corresponding dose planes for an abdominal kV-CBCT
scan of a pediatric patient in the prone position. Doses were calculated with the Monte Carlo
technique, the density-corrected-only dose-to-water, and the MDC-DA. (Middle) Sagittal
slice and corresponding dose planes for a pediatric abdominal kV-CBCT scan. (Bottom)
Dose profiles through lines AB and CD.
close to the spine and ribs, but is accurate for regions far from bone where a significant
portion of the photon fluence has not been attenuated by bone. The spinal cord presents the
worst-case scenario for a soft-tissue structure calculated with the dose-to-water technique
since it is completely surrounded by bone and thus receives a significantly reduced fluence.
This results in dose overestimation of approximately 40% with the dose-to-water calculation.
The MDC-DA calculation models the effects of bone on the dose distribution and results
in a significant accuracy improvement, reducing the dose error to less than 10% along this
line segment for the spinal cord.
Figures III.5 and III.6 show the results of the dose calculations for the Adult Pelvis
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3 patient and the Adult Chest 4 patient. The dose to bone is highly inhomogeneous, with
the largest doses in portions of bone that are closest to the surface of the patient. The MDC-
DA accurately accounts for the geometric distribution of these inhomogeneities. The dose
volume histograms (DVHs) compare the results of calculations with the MDC-DA and the
dose-to-water calculations to the Monte Carlo distributions for specific organs. Dose volume
histograms are commonly used in radiation therapy to characterize the dose delivered to
organs. A point on a DVH curve denotes the percentage of the volume of an organ that
is receiving a dose greater than or equal to that specified on the abscissa. For example, if
a point on a DVH curve corresponds to 90% of the volume and 10 cGy, then 90% of the
organ is receiving at least 10 cGy. The dose-to-water calculation results in a significant
underestimation of the dose to the femoral heads and ribs, and overestimates the dose to
the soft-tissue structures. The MDC-DA shows a significant improvement in the accuracy
of calculating the dose to soft-tissue and bone organs-at-risk.
Figure III.7 shows the results of the dose calculations for the Adult legs patient
from a kV-CBCT scan. Whereas the dose-to-water calculation underestimates the dose to
bone, this calculation is accurate for soft-tissue voxels that are not immediately adjacent
to bone. Due to the geometry of bone in this patient, most soft-tissue voxels are irradiated
by a photon fluence that has only minimally been perturbed by the passage though bone.
This effect is accounted for in the MDC-DA since correction factors along rays that do not
intersect bone are set to unity.
Table III.3 summarizes the results of the dose calculations performed on each
patient. The mean dose to bone and soft-tissue voxels in cGy calculated for the region
being imaged for each patient for a single kV-CBCT scan is shown. The doses reported are
for the Monte Carlo calculation, the dose-to-water calculation, the MDC-DA calculation
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Figure III.5: Axial CT slice (a) and corresponding dose planes in colorwash (b-d) for a
kV-CBCT scan of the Adult Pelvis 3 patient. The Monte Carlo (b), dose-to-water (c),
and MDC-DA (d) calculations are shown. (e) DVHs calculated from the Monte Carlo
distributions (solid) compared to dose-to-water calculation (dashed) for organs at risk in
the pelvis. (f) Monte Carlo calculated DVHs (solid) compared to the MDC-DA calculation
(dashed).
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Figure III.6: Axial CT slice (a) and corresponding dose planes in colorwash (b-d) for a
kV-CBCT scan of the Adult Chest 4 patient. The Monte Carlo (b), dose-to-water (c),
and MDC-DA (d) calculations are shown. (e) DVHs calculated from the Monte Carlo
distributions (solid) compared to dose-to-water calculation (dashed) for organs at risk in
the pelvis. (f) Monte Carlo calculated DVHs (solid) compared to the MDC-DA calculation
(dashed).
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Figure III.7: Coronal CT slice (a) and corresponding dose planes in colorwash (b-d) for
a kV-CBCT scan of the Adult Legs patient. The Monte Carlo (b), dose-to-water (c),
and MDC-DA (d) calculations are shown. (e) Dose profiles along line AB for each dose
calculation method.
using the average parameter set, and the simple correction method of multiplying the dose-
to-water by the ratio of the bone-to-water mass-energy absorption coefficients. The absolute
dose to patients can vary by more than an order of magnitude depending on patient size,
imaging site, and acquisition technique. The mean dose to bone voxels varies from 2.1 to
3.5 times the mean dose to soft-tissue voxels across patients. The dose-to-water calculation
underestimates the mean bone dose by up to -64%, with an average error of -60%. In
contrast, the simple correction method overestimates the mean bone dose by 28% to 63%.
The MDC-DA method using the average model parameter set is accurate to within -4%
to 7% for mean bone dose calculation. For soft-tissue voxels, the dose-to-water calculation
technique overestimates the mean dose by up to 21%. The MDC-DA method results in
mean soft-tissue dose errors that are within -3 to 5%.
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III.1.4 Discussion and conclusions
We have presented a new algorithm to calculate medium-dependent correction
factors for kV x-rays that accounts for the effects of differential absorption rates in bone
relative to the soft tissues in the human body.
We have benchmarked the accuracy of the MDC-DA for the calculation of imaging
dose from kV-CBCT by comparing dose calculations performed with this method to Monte
Carlo dose-to-medium distributions. We showed that the MDC-DA algorithm is capable
of calculating the imaging dose from kV-CBCT acquisitions that use the half-fan (360◦
source rotation) and full-fan (200◦ source rotation) scanning techniques. In this work we
used a single set of model parameters to calculate the medium-dependent correction factors
for all patients. The results of dose calculations using this parameter set were within 7%
mean dose error for bone, and 5% mean soft-tissue dose error for each of the 14 patients
studied. Potential improvement of these results could be obtained if the separate model
parameter sets obtained for each imaging site were used for patients with similar imaging
sites; however, this would make the implementation unwieldy in practice.
The MDC-DA algorithm was shown to be superior to a simple correction method
by which the medium-dependent effect is accounted for by multiplying the dose-to-water
distribution by the ratio of the bone-to-water mass-energy absorption coefficients. The free-
in-air mass-energy absorption coefficient ratio overestimates the medium-dependent effect
for bone voxels as the energy used to determine this factor was that of the unattenuated
beam. Moreover, from Table III.3 we see that the ratio of the mean dose to bone calculated
with Monte Carlo to the mean dose to bone calculated with the dose-to-water calculation
varied from 2.3 to 2.9 for the patients studied, indicating that a single scalar multiplication
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is insufficient to correct for medium-dependent effects when considering variations in patient
size and imaging site.
The MDC-DA as presented here can be used to extend model-based radiotherapy
treatment planning systems to accurately calculate the dose-to-medium delivered to patients
from kilovoltage x-rays, and thus facilitate the recording and management of the radiation
dose that patients receive from kilovoltage imaging.
III.2 The effective approach to medium-dependent correction
III.2.1 Introduction
In the previous section the MDC-DA was developed which corrected dose-to-water
calculations for the effects of photoabsorption in bone. The corrections for both soft-tissue
and bone are based on an empirical parameterization of the medium-dependent correction
along rays incident on the patient from the x-ray source. Model parameters were empirically
obtained by fitting the model to gold-standard correction factor distributions obtained for
multiple patients using the Monte Carlo method. For the patients studied the corrected dose
distributions were within 7% for bone and 5% for soft-tissues. To improve on this accuracy
it is necessary to use more than one model parameter set, with each set of parameters
optimized for use with a specific body site, such as the head-and-neck, pelvis, chest, etc. As
Table III.2 shows, there is some variation in optimal model parameters obtained individually
for different patients. In practice the approach of using separate model parameters for
different imaging sites would be cumbersome to implement. It would also be impossible to
implement for CT imaging procedures that are not limited to a single anatomical region,
such as a full-body scan. To overcome this potential limitation we have developed a second
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approach to determine the medium-dependent corrections for kilovoltage x-rays, which is
to be described in this section.
This new approach is based on the hypothesis that the correction factors needed
to convert dose from model-based dose-to-water calculations to absorbed dose-to-medium
depend on both the attenuation characteristics of the absorbing media and the changes to
the energy spectrum of the incident x-rays as they traverse media with an effective atomic
number different than that of water. To explore this hypothesis, Monte Carlo simulation
techniques were used to generate empirical medium-dependent correction factors that take
both effects into account. We found that the correction factors could be expressed as
a function of a single intermediate quantity, called the effective bone depth, which is a
measure of the average thickness of bone that an x-ray beam must penetrate to reach a
voxel. This new correction method is referred to as the Medium-Dependent Correction–
Effective Approach (MDC-EA) . In the following, we describe the method in detail and show
its application for calculating the dose to patients resulting from kV-CBCT image guidance
procedures. The calculation accuracy of this new approach is validated by comparing the
dose distributions obtained using the MDC-EA to those calculated with the Monte Carlo
technique.
III.2.2 Methods
Monte Carlo simulation of dose correction factors
Using the Monte Carlo techniques described by Ding and Coffey [28], we calculated the
imaging dose-to-medium (DM) delivered to 14 patients from kV-CBCT scans for multiple
imaging sites including the head-and-neck (H&N), pelvis, chest, abdomen, and legs. The
x-ray beams used were from the Varian on-board imager (OBI) system integrated into a
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Table III.4: kV-CBCT acquisition techniques used for dose calculation for each patient in
this study. Each kV-CBCT x-ray beam simulated was from Varian’s OBI system. (Repro-
duced from [66] with permission)
Patient CBCT acquisition technique X-ray Voltage (kVp)
Adult H&N 1a OBI 1.3 125
Adult H&N 2 OBI 1.4 standard-dose head 100
Adult H&N 3 OBI 1.4 standard-dose head 100
Adult H&N 4 OBI 1.4 standard-dose head 100
Pediatric H&N 1a OBI 1.3 125
Adult pelvis 1a OBI 1.3 125
Adult pelvis 2 OBI 1.4 pelvis 125
Adult pelvis 3 OBI 1.4 pelvis 125
Adult chesta OBI 1.3 125
Adult chest OBI 1.4 low-dose thorax 110
Adult chest OBI 1.4 low-dose thorax 110
Adult chest OBI 1.4 low-dose thorax 110
Adult legs OBI 1.4 pelvis 125
Pediatric abdomen OBI 1.4 low-dose thorax 110
a Patients used to derive correction factor curves.
TrilogyTM linear accelerator (Varian Medical Systems, Palo Alto, CA). The acquisition tech-
niques used were the clinical default protocol half-fan beam from OBI version 1.3 described
by Ding et al. [32], and the OBI 1.4 Standard-Dose Head, Pelvis, and Low-Dose Thorax
techniques described by Ding et al. [34]. Table III.4 lists the acquisition techniques used
for each patient in the study. The kV-CBCT beams were simulated using the BEAMnrc
code [68], and dose calculations were performed with the DOSXYZnrc usercode [53, 78].
The calculation volumes for each patient were created from volumetric CT images
taken of the patients for the purpose of radiotherapy treatment planning. Four materials
were used for dose calculation: air, lung, soft-tissue, and cortical bone. Material type was
assigned to each voxel based on the physical density of the voxel, which was determined
from a CT number to density calibration curve. Density ranges for each material were
0.001–0.044 g/cm3 for air, 0.044–0.302 g/cm3 for lung, 0.302–1.101 g/cm3 for soft-tissue,
and 1.101–2.088 g/cm3 for bone. A second Monte Carlo calculation was performed for
all patients in which dose distributions were obtained by accounting for density inhomo-
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geneities, but neglecting medium-dependent effects. This was done by setting all materials
in the calculation volume to water and scaling the density of each voxel according to a CT
number to density calibration curve. The resulting density-corrected-only dose distribu-
tion (DDCO) is consistent with the model-based superposition/convolution calculations of
chapter II and Alaei et al. [3]. The gold standard matrix of correction factors, fc (x, y, z),
that converts the density-corrected-only dose distribution to dose-to-medium was found for
each patient by taking the ratio of the doses to corresponding voxels resulting from each
calculation:
fc (x, y, z) =
DM (x, y, z)
DDCO (x, y, z)
. (III.7)
Effective bone depth calculation
Using patient material and density data derived from CT images, the x-ray beam fluence
profile, and the imaging isocenter, we calculated the effective bone depth that the x-ray
beam penetrates to reach each voxel, dEB . This quantity was calculated by first modeling
the rotating x-ray source of the OBI system used for kV-CBCT acquisition as a set of evenly
spaced discrete incident beams, and calculating the thickness of bone, dB, that rays parallel
to the primary beam pass through to reach each voxel. The effective bone depth was then
calculated for each voxel by computing an average of the bone thicknesses for each ray
to reach each voxel, weighted by a function that specifies the contribution of each of the
individual rays to the effective bone depth at each voxel:
dEB (x, y, z) =
∑
iw (x, y, z)i · dB (x, y, z)∑
iw (x, y, z)i
(III.8)
where the sum in Equation III.8 is over each incident beam. The weighting function,
w, depends on the x-ray beam fluence profile (I (x, y, z)), the source-to-voxel distance
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(SV D (x, y, z)), and the bone thickness for each incident ray. In this work, the weight-
ing function used was:
w (x, y, z) =
I (x, y, z)
dB (x, y, z)
2 +
(
SV D(x,y,z)
a
)2 , (III.9)
where a is a constant used to scale the relative weight of SV D and dB .
For each kV-CBCT acquisition technique except for the OBI 1.4 Standard-Dose
Head a 360◦ rotation of the x-ray source was used, and was modeled by utilizing 16 incident
rays separated by 22.5◦ to calculate the effective bone depth. We found that there was a
negligible difference in effective bone depth distributions if the number of incident rays was
increased from 16 to 360. The Standard-Dose Head technique utilizes a 200◦ posterior arc
of the x-ray source with x-ray incidence spanning from a supine patient’s left lateral side
to a right anterior oblique incidence. This 200◦ arc was modeled using 10 incident beams
separated by 20◦ to calculate the effective bone depth.
Correction factor curve determination and dose calculation
Monte Carlo simulation and effective bone depth calculations were carried out as described
above for the 14 real patients included in this study. These patients were divided into two
groups: (1) four patients were used to derive correction factor curves from the correlation
between the effective bone depth and dose correction factor, and (2) ten patients were used
as test cases to validate the use of the curves for dose calculation. The imaging sites for
the first data set included an adult H&N, a pediatric H&N, an adult pelvis, and an adult
chest. The remaining patients used for validation included imaging sites such as the adult
H&N, chest, pelvis, pediatric abdomen, and the legs.
To derive correction factor curves as a function of effective bone depth, the gold
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standard correction factors and corresponding effective bone depths for all voxels of all pa-
tients in group 1 were combined into a single data set. This data set was then investigated to
obtain a general correlation of the correction factor as a function of effective bone thickness
individually for bone and soft-tissue:
fc (dEB) =

fbonec (dEB) , bone voxels
f soft-tissuec (dEB) , soft-tissue voxels
(III.10)
The derived curves were used for dose calculation for each patient by calculating the effec-
tive bone depth distributions and applying the resulting correction factor to the density-
corrected-only calculation:
DM (x, y, z) = DDCO (x, y, z) fc (dEB (x, y, z)) . (III.11)
Validation of the dose calculations was performed by comparing the resulting dose distri-
butions to Monte Carlo dose distributions calculated for each patient.
III.2.3 Results
Monte Carlo simulation of dose correction factors
Figure III.8 shows an axial slice through the kV-CBCT image of an adult H&N patient
and the dose correction factors for voxels in this slice. Dose correction factors are generally
greater than one for bone voxels and are typically in the range of 2–3. Soft-tissue voxels
generally have dose correction factors less than one. Bone voxels on the periphery of the
skull have the largest correction factors, as the primary x-ray beam has not been attenuated
by bone prior to irradiation of these voxels for a portion of the rotation of the x-ray source
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Figure III.8: (a) Axial CT slice through an adult H&N kV-CBCT image. (b) The dose
correction factor distribution calculated with Monte Carlo for the slice shown in (a). Note
that the values of the correction factors are not constant for all voxels of the same medium.
Bone and soft-tissue voxels interior to the skull tend to have smaller correction factors due
to the lack of low-energy x-rays at these locations. (Reproduced from [66] with permission)
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Figure III.9: The calculated effective bone depth distribution for the adult H&N kV-CBCT
slice shown in Figure III.8. Regions of high effective bone depth are in the interior portions
of the skull where the dose correction factors tend to be the lowest. Low effective bone depth
regions are on the periphery of the skull where the primary beam is directly incident on
these voxels before traveling through bone for part of the x-ray source rotation. (Reproduced
from [66] with permission)
around the skull. Voxels interior to the skull tend to have smaller correction factors as the
low energy x-ray fluence is heavily depleted at these locations due to photoabsorption in
bone.
Effective bone depth calculation and correction factor curves
Figure III.9 shows an example of the effective bone depth distribution calculated for the axial
slice shown in Figure 1. High effective bone depth was calculated in regions in or near thick
bones; lower values of effective bone depth are seen in the soft-tissues in the periphery of the
patient, and on the most exterior bone surfaces. The effective bone depth distribution shown
in Figure III.9 was calculated using the 16 incident rays separated by 22.5◦ as described
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in Section 2.1. We performed similar calculations with 4, 8, 32, 64, and 360 incident
rays and found that calculations using less than 16 rays resulted in effective bone depth
distributions that inadequately characterized the distribution of bone in the patient, and
calculations using more than 16 incident rays did not show significant improvement to justify
the additional calculation time.
Dose correction factors and effective bone depth distributions were calculated for
each of the patients in the first data set with the intent of correlating the two quantities.
FigureIII.10 (left) shows a scatter plot of correction factor versus effective bone depth
showing data from all bone voxels and soft-tissue voxels of each patient in the first group.
Each point in the scatter plot corresponds to a single voxel. In total, this plot shows data
from nearly 3 × 105 bone voxels and more than 3 × 106 soft-tissue voxels. The red lines
in Figure III.10 are least-square fits to the combined data set and give the dose correction
factors as a function of effective bone depth separately for bone and soft-tissue voxels. The
functional form of the correction factor curves was obtained using an online curve fitting
application [46]. The equations for these curves are
fbonec = 3.6258− 2.1422
1−(1 + ( dEB
4.4518
)1.5171)−3.3769 (III.12)
f soft-tissuec =
(
2.0953 + 6.7997 · d4.5429EB
)0.07178
. (III.13)
Figure III.10 (right) shows the scatter plots of dose correction factor vs. effective
bone depth for each individual patient in the first group, along with the curves obtained
for the combined data set. The obtained curves fit each individual patient distribution,
suggesting that the effective bone thickness is a good surrogate for explicit calculation of
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Figure III.10: (Left) Scatter plot of dose correction factor fc and effective bone depth (dEB)
for the combined data set of patients in group 1. Each point on the plot corresponds to a
single voxel; a total of nearly 3×105 bone voxels and more than 3×106 soft-tissue voxels are
shown. The red lines are least-square fits that give the dose correction factor as a function
of effective bone depth separately for bone and soft-tissue voxels. (Right) Scatter plots of
dose correction factor versus effective bone depth for each individual patient in group 1 with
the least-squares fit lines from the combined data set. The lines shown here are used as
correction factor curves for dose calculation throughout this work. (Reproduced from [66]
with permission)
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the correction factor at a given voxel, regardless of patient type or imaging site.
The weighting function used to combine the bone depths from each incident di-
rection into the effective bone depth is given by Equation III.8. Neglecting the bone depth
term, the weighting function is simply the product of the photon fluence profile and the
inverse square divergence of the beam, which was the intuitive starting point for determin-
ing the relative contribution of each beam direction to the weighted average. We found,
however, that the inclusion of the effective bone depth term in the denominator reduced the
relative error of the dose correction factor correlation curves, ie. the scatter plots of dose
correction factor vs. effective bone depth showed less dispersion. This was quantified by
binning the dose data shown in these plots into effective bone depth bins, and calculating
the standard deviation error for each bin. Multiple test functions were attempted, with the
function shown in Equation III.8 resulting in the smallest errors overall.
Dose calculation with the MDC-EA
Dose calculations were carried out as described above for each of the 10 patients in the second
patient group using Equations III.12 and III.13 to convert effective bone depth to dose
correction factor. Example calculated dose distributions are shown in Figures III.11, III.12,
and III.13 for the Adult H&N 4, Adult Pelvis 3, and Adult Chest 2 patients, respectively.
The dose calculation for Adult H&N 4 was performed with the OBI 1.4 Standard-Dose
Head scanning technique which utilizes a 200◦ posterior rotation of the x-ray source. The
Monte Carlo calculations show the enhanced dose to bone, which is most prominent in the
regions which are directly irradiated by the primary x-ray beam. The density-corrected-only
calculations result in a relatively homogeneous dose distribution as photoabsorption in bone
is not accounted for. The MDC-EA calculations correct for the effects of photoabsorption
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in bone on the dose distribution by enhancing the dose to bone and decreasing the dose
to the surrounding soft-tissues. Note from the profile along line AB in Figure III.12 that
the dose-to-medium does not always trend with the density-corrected-only distribution.
Simple application of a constant multiplicative correction factor would incorrectly predict
the shape of the Monte Carlo distribution; however, the MDC-EA accurately models the
dose-to-medium. The thoracic CT scan dose planes and profiles shown in Figure III.13 show
that the MDC-EA is capable of accurately calculating the radiation dose to lung, as well as
other soft-tissues and bone.
Table III.5 shows the mean dose to bone, soft-tissue, and lung voxels calculated
with the Monte Carlo, density-corrected-only, and MDC-EA techniques for each patient.
The magnitude of the imaging dose depends on imaging site, patient size, and acquisition
technique, varying by roughly an order of magnitude across all patients studied. An exami-
nation of the accuracy of the MDC-EA across this group of patients is thus easiest done in a
relative fashion. Table III.6 shows the mean and standard deviation dose errors normalized
to the maximum soft-tissue dose to each patient calculated for the density-corrected-only
calculations and the MDC-EA calculations for each patient. The density-corrected-only
calculations result in mean bone dose errors up to -103%, with standard deviations of the
distributions approaching nearly 40%. The MDC-EA is capable of correcting the mean
bone dose to within 2.55% for all patients and the standard deviation dose errors to within
13.49%. The density-corrected-only calculations produced mean dose errors of up to 8.18%
for soft-tissue voxels, whereas the MDC-EA corrected each distribution to within 1.26% of
the gold-standard. The standard deviation dose errors for the soft-tissue voxels were as
high as 6.61% for the density-corrected-only calculations, but were within 3.22% for the
MDC-EA calculations.
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Figure III.11: Dose planes calculated for a single kV-CBCT scan of patient adult H&N 4.
Axial (top) and sagittal (bottom) planes are shown for the Monte Carlo calculation (left),
the density-corrected-only calculation (middle), and the MDC-EA calculation (right). The
kV-CBCT acquisition mode used was the OBI 1.4 Standard Head with a full bow-tie filter
and 200◦ posterior rotation of the x-ray source. (Reproduced from [66] with permission)
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Figure III.12: Single kV-CBCT scan dose planes and line profiles for the Adult Pelvis 3 pa-
tient. The Monte Carlo calculation (top left) shows the highly inhomogeneous dose distribu-
tion in the bony pelvis that is completely neglected in the density-corrected-only calculation
(top middle). The MDC-EA calculation (top right) is capable of accurately accounting for
the medium-dependent effect on the bone dose. The line profiles show that the soft-tissue
dose is considerably affected by the medium-dependent effect. The density-corrected-only
calculations overestimate the soft-tissue dose in the proximity of bone; however, the MDC-
EA calculation accounts for the medium-dependent effect. (Reproduced from [66] with
permission)
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Figure III.13: Single kV-CBCT scan dose planes and line profiles for an axial slice through
the thorax of the Adult Chest 2 patient. The dose to the lungs is accurately calculated
with the MDC-EA calculation, even though the soft-tissue correction factor curve is used
for lung tissue voxels. (Reproduced from [66] with permission)
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Figure III.14: Dose error histograms for bone voxels (left) and soft-tissue voxels (right) for
an adult H&N (top), an adult chest (middle), and a pediatric abdomen (bottom) kV-CBCT
scan. The errors are normalized to the maximum soft-tissue dose calculated with Monte
Carlo. The long negative percent error tails shown for the density-corrected-only calculated
bone dose distributions are typical for this calculation technique. (Reproduced from [66]
with permission)
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Figure III.14 shows example dose error histograms for the Adult H&N 3 (top),
Adult Chest 4 (middle), and Pediatric Abdomen (bottom) patients. Bone error distribu-
tions (left), and soft-tissue error distributions (right) are shown for each patient for the
density-corrected-only and MDC-EA calculations. The distributions were calculated rela-
tive to the maximum dose to soft-tissue for each patient. The density-corrected-only calcu-
lations produce bone error distributions with long negative dose error tails as the enhanced
dose to bone from photoabsorption is not accounted for in these calculations. The MDC-
EA calculation both centered the bone dose error distribution about 0% and significantly
reduced the spread in the dose-error distribution, as was indicated in Table III.6. Similar
results are shown for soft-tissue, though the magnitude of dose correction is less than that
for bone.
Figure III.15 shows dose-volume histograms (DVHs) for bone and soft-tissue struc-
tures for the Adult H&N 3 (top), Adult Pelvis 2 (middle), and Adult Chest 4 patients
(bottom). Distributions for the spine, femoral head, ribs, parotid gland, bladder and lung
are shown. The soft-tissue structures tend to have homogeneous dose distributions, whereas
the dose distributions of bony structures are by comparison inhomogeneous. The MDC-
EA is capable of accurately accounting for the medium-dependent effect, reproducing the
dose distributions to individual organs for each patient despite the disparate anatomies sur-
rounding these structures, and is a significant improvement over the density-corrected-only
calculations.
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Figure III.15: DVHs calculated for bony and soft-tissue structures of three patients in this
study. The density-corrected-only calculation results in significant underestimation of bone
dose and overestimates the soft-tissue structure dose. The MDC-EA accurately reproduces
the dose distributions for each structure of each patient using a single set of correction
factor curves to correct the density-corrected-only distributions. (Reproduced from [66]
with permission)
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III.2.4 Discussion and conclusions
The new correction method was tested for imaging dose calculations for patients re-
sulting from different kV-CBCT acquisition techniques. The accuracy of this new approach
was compared with the Monte Carlo method, which is regarded as the gold standard. For
all patients studied, the new approach resulted in mean dose errors of less than 3%. This is
in contrast to currently available density corrected methods which resulted in mean errors
of up to -103% for bone and 8% for soft-tissue. A limitation to this benchmark is that only
four media were used in the Monte Carlo simulations: air, lung, soft-tissue, and cortical
bone. This amounts to neglecting the differences in absorption characteristics between adi-
pose tissue and soft-tissue, and between cortical bone and the bone spongiosa consisting
of trabecular bone and red bone marrow. The difference in absorption between different
soft tissues and between spongiosa and cortical bone may be accounted for by using a
second-order correction factor that characterizes the differences in absorption between the
two materials
An additional source of error for this approach arises from tissue segmentation
uncertainty. This difficulty is not unique to the proposed correction method; any calculation
technique relying on tissue segmentation, including the Monte Carlo technique, is susceptible
to errors in the segmentation process resulting from volume averaging, image noise, inter-
patient variations of tissue densities, implanted prostheses, and image artifacts. Potential
advancements in dual-energy CT could result in more accurate tissue segmentation [10],
which would be particularly beneficial to kV dose calculations due to the steep dose gradients
at the boundaries of atomic number inhomogeneities.
In this work, we applied the medium-dependent correction factors to density-
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corrected-only dose distributions obtained by Monte Carlo simulation. It has been shown
by Alaei et al. [5, 6] that model-based radiotherapy treatment planning systems are capable
of calculating density-corrected-only dose-to-water distributions from kV x-rays. The new
correction approach can thus be used in conjunction with a commissioned kV-CBCT x-
ray beam in a model-based treatment planning system, such as demonstrated by Alaei
et al. [3], to accurately calculate the radiation dose from kV-CBCT without the use of
Monte Carlo. The new approach thus has potential to extend the applicability of current
and widely available radiotherapy treatment planning systems to accurately calculate the
radiation dose to patients from kV x-rays. In chapter IV we present results of dose-to-
medium calculations using the MDC-EA to correct dose-to-water distributions obtained
with the algorithm developed in chapter II.
The correction method proposed here has numerous advantages over existing meth-
ods to calculate dose from kV x-rays including in-medium effects. The main advantage is
that model-based dose calculation algorithms are widely used in commercial radiotherapy
treatment planning systems, which makes accounting for the additional dose to patients
resulting from repeated image guidance procedures readily feasible. Secondly, a simple cor-
rection method based on multiplying the density-corrected-only dose to bone by the ratio
of the bone-to-water mass-energy absorption coefficients has been shown to be inaccurate
since it is difficult to characterize a priori the energy spectrum at a given voxel for compli-
cated geometries, such as volumes based on patient CT data [3]. Furthermore, the simple
correction method does not correct the dose to soft-tissues in the vicinity of bone that are
irradiated by a reduced fluence relative to the uncorrected calculation. Another empirical
correction method, the Medium-Dependent Correction-Direct Approach (MDC-DA) has
been proposed by Ding et al. [35] which takes into account the effects of photoabsorption in
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bone on the dose-distribution including corrections for bone and soft-tissue. This method
has been shown to be accurate for patient dose calculation when using empirically parame-
terized correction factors specifically obtained for a particular imaging site and patient size;
however separate model parameters must be used for each permutation of imaging site,
patient size, and beam quality, making implementation difficult in practice.
It is worth noting that the calculation speed of the new approach is about two
orders of magnitude faster than the Monte Carlo method. For example, the calculation
times required to generate the correction factors using a single Intel Pentium D 3.73 GHz
processor ranged from 3.2 minutes for the pediatric H&N patient (538,428 voxels calculated
in a CT voxel space of 100×140×140 voxels) to 27.0 minutes for Adult Pelvis 2 (3,395,577
voxels calculated in a CT voxel space of 176×200×200 voxels). Dose-to-water calculations
performed using a commissioned kV-CBCT beam in the Philips PINNACLE treatment
planning system v8.0 (Philips Medical Systems, Milpitas, CA) add 30-60 minutes to the
calculation using a serial computation. Our implementation of the MDC-EA algorithm
could easily be parallelized, providing a reduction in calculation time proportional to the
number of processors used. The Monte Carlo simulations used in this study had calculation
times ranging from four to five days on a single processor.
In conclusion, we have presented a new approach of using Monte Carlo techniques
to obtain empirical medium-dependent correction factors. It is seen that the correction
factors can be expressed as a function of a single quantity, called the effective bone depth,
which is a measure of the amount of bone that an x-ray beam must penetrate to reach a
voxel. Due to the manner in which the effective bone depth is calculated, this method is able
to take into account the effects of both the attenuation characteristics of the absorbing media
and the changes to the energy spectrum of the incident kV x-rays as they traverse through
84
different media. This new approach has potential to overcome the accuracy deficiency of
model-based dose calculation algorithms for kV beams and to extend current model-based
calculation algorithms used in commercial treatment planning systems to calculate the
additional radiation exposure resulting from repeated daily imaging guidance procedures
that use diagnostic energy photon beams.
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IV Validation of the algorithm for the calculation of radiation dose to
real patients from x-ray imaging procedures
IV.1 Introduction
In chapter II we presented a new model-based convolution/superposition algo-
rithm to calculate the dose to water-equivalent media from kilovoltage x-ray beams, and
presented the results of applying the algorithm to simple geometric phantoms. In chapter III
we developed two methods to determine medium-dependent correction factor distributions
to convert dose-to-water distributions to dose-to-medium distributions that account for the
effects of photoabsorption in bone. These correction factor distributions were applied to
dose-to-water calculations performed with the Monte Carlo technique to obtain dose-to-
medium distributions. Benchmarking these correction methods was done by comparing
these dose-to-medium distributions to Monte Carlo calculated dose-to-medium distribu-
tions.
In this chapter we implement the model-based convolution/superposition dose cal-
culation algorithm developed in chapter II to calculate dose-to-water distributions for radio-
therapy patients resulting from kV-CBCT imaging and single-angle projection imaging. We
then obtain dose-to-medium distributions by correcting these dose-to-water distributions us-
ing the MDC-EA algorithm. These calculations are benchmarked against dose distributions
obtained using the Monte Carlo technique.
Dose calculations for these procedures are of importance as they deliver additional
radiation dose to patients that is not accounted for in the treatment planning process.
They are also potentially repeated daily for as many as 25-40 treatments, which can result in
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significant radiation exposure. As the dose from image guidance is added to regions receiving
high therapeutic doses with inhomogeneous distributions, it is necessary to have accurate
three-dimensional radiation dose calculations for kV imaging procedures to facilitate dose
summation. There are a multitude of studies that have experimentally measured and/or
calculated the imaging dose from IGRT [24, 28, 30, 33, 38, 51, 60, 77, 79], however, no
method is currently employed in routine clinical practice to calculate the additional dose to
patients from these procedures.
IV.2 Methods
The dose calculations in this chapter are performed using the algorithms developed
in chapters II and III. The dose-to-medium distribution is obtained by multiplying the dose-
to-water matrix by the medium-dependent correction factor distribution:
Dmedium (x, y, z) = MDC (x, y, z)×Dwater (x, y, z) . (IV.1)
The dose-to-water distribution is calculated using the model-based convolution/superposition
algorithm developed in chapter II. For patient dose calculations from kV-CBCT the rota-
tion of the x-ray source was discretized into a finite number of incident beams separated by
5◦ . Dose-to-water calculations were individually performed for each beam and combined
to generate the total dose-to-water distribution.
The medium-dependent correction factor distributions were obtained using the
MDC-EA algorithm developed in chapter III. Correction factor distributions for the full
360◦ scans were obtained by calculating the effective bone depth along 16 incident rays.
The standard dose head technique utilizes a 200◦ posterior scan which was modeled with 10
incident rays to calculate the effective bone depth. For the single-angle projection imaging
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calculation a single ray incident parallel to the x-ray beam was used to calculate the effective
bone depth.
The Monte Carlo calculations presented in this chapter were performed as de-
scribed by Ding et al. [28, 34]. The x-ray beams were simulated using the BEAMnrc
code [68], and dose calculations were performed with the DOSXYZnrc usercode [53, 78].
Dose-to-medium calculations were performed with consideration of four materials: air, lung,
soft-tissue, and cortical bone. The material type was assigned to each voxel of the CT data
based on the physical density of the voxel, which was determined from a CT number to
density calibration curve. The density ranges for each material were 0.01-0.044 g/cm3 for
air, 0.044-0.302 g/cm3 for lung, 0.302-1.101 g/cm3 for soft tissue, and 1.101-2.088 g/cm3
for bone [78]. Dose-to-water calculations were performed by setting all materials in the cal-
culation volume to water and scaling the density of each voxel according to the CT number
to density calibration curve.
The simulated x-ray beams were from the Varian on-board imager (OBI) system
integrated into a TrilogyTMlinear accelerator (Varian Medical Systems, Palo Alto, CA). The
acquisition techniques used were the Varian OBI version 1.4 standard-dose head, pelvis, and
low-dose thorax techniques described by Ding et al. [34]. The standard-dose head technique
uses the full-fan bowtie filter, while the pelvis and low-dose thorax techniques use half-fan
bowtie filter. The x-ray energies are 100 kVp for the head technique, 110 kVp for the
thorax, and 125 kVp for the pelvis.
IV.3 Results
Figures IV.1–IV.3 show dose calculation results for a kV-CBCT scan taken of a
male pelvis using the pelvis x-ray beam, an adult head imaged with the standard-dose head
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technique, and a female breast cancer patient set up on a breast board imaged with the low-
dose thorax technique. For the pelvis and chest calculations 72 incident beams separated
by 5◦ were used for the model-based dose-to-water calculation. The head scan is done with
a 200◦ posterior source rotation spanning from the patient right anterolateral side to the
left lateral side. The model-based dose calculation for this scan utilized 41 incident beams
separated by 5◦ . The dose-to-water distributions all show excellent agreement with the
Monte Carlo dose-to-water calculations.
The dose-to-medium distributions were calculated for each patient using the MDC-
EA to correct the dose-to-water distributions for the effects of bone on the dose distribution.
The dose-to-medium results show the enhanced dose to bone due to photoabsorption, and
the decreased dose to the surrounding soft tissues as a result of the corresponding decrease
in photon fluence in these areas. The dose to bone is typically on the order of 2–3 times
greater than the dose to the surrounding soft tissue. The dose-to-medium calculations show
acceptable accuracy compared to the Monte Carlo calculations.
Similar calculations were performed for kV-CBCT scans of additional pelvis, head,
and chest patients. Table IV.1 shows the mean and standard deviation dose errors for the
dose-to-water calculations for each patient, normalized to the maximum dose-to-water in the
irradiated volume. Dose errors were calculated relative to the Monte Carlo dose-to-water
distributions to reveal the accuracy of the convolution/superposition model-based method
alone. Voxels that are superior or inferior to the primary beam were excluded from the
calculation of the mean and standard-deviation error. The results show mean dose errors
less than 0.3% for each patient. Standard deviation dose errors were within 2.0% for the
pelvis scans, 2.6% for the chest, and 4.1% for the H&N. The results shown in Figures IV.1-
IV.3 correspond to the patients labeled Pelvis 2, Chest 2, and H&N 2 respectively.
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(a) Coronal view of patient CT data
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(b) Monte Carlo dose calculation
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(c) Model-based dose calculation
80 100 120 140
profile [voxel]
0
1
2
3
4
5
6
7
d
o
se
 [
cG
y
]
Anterior-posterior profile
MC: dose-to-medium
Model: dose-to-medium
MC: dose-to-water
Model: dose-to-water
(d) Dose profile along anterior-posterior axis
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(e) Lateral dose profiles
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(f) Inferior-superior dose profiles
Figure IV.1: Results for calculations performed for the standard-dose pelvis kV-CBCT
beam irradiating an adult male pelvis patient.
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(a) Transverse view of patient CT data
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(b) Monte Carlo dose calculation
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(c) Model-based dose calculation
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(d) Dose profile along anterior-posterior axis
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(e) Lateral dose profiles
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(f) Inferior-superior dose profiles
Figure IV.2: Results for calculations performed for the standard-dose head kV-CBCT beam
irradiating an adult head. The x-ray beam rotates posteriorly around the patient resulting
in the observed dose gradient in the anterior-posterior direction.
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(b) Monte Carlo dose calculation
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(c) Model-based dose calculation
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(d) Dose profile along anterior-posterior axis
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(e) Lateral dose profiles
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Figure IV.3: Results for calculations performed for the low-dose thorax kV-CBCT beam
irradiating a female breast patient set up on a breast board.
92
Table IV.1: Relative dose errors for the model-based dose-to-water calculation relative to
the Monte Carlo dose-to-water calculation. Dose errors are normalized to the maximum
dose-to-water in the irradiated volume.
Patient Mean dose error (% ± 1 σ)
Pelvis 1 -0.1 ± 2.0
Pelvis 2 -0.3 ± 1.7
Chest 1 -0.3 ± 2.7
Chest 2 -0.2 ± 2.4
H&N 1 -0.3 ± 3.0
H&N 2 -0.1 ± 3.0
H&N 3 -0.2 ± 4.1
Table IV.2 shows mean and standard deviation dose errors for the patient dose
calculations compared to the Monte Carlo dose-to-medium calculations. Results are shown
for the model-based calculation alone, and for the model-based calculation corrected with
the MDC-EA. Dose errors were separately calculated for bone, soft tissue, and lung voxels,
and are normalized to the maximum dose to soft tissue in the irradiated volume. The
uncorrected dose-to-water distributions show significant underestimation of the dose to
bone, with an average dose error of -60.2%. Dose to soft tissues, on the other hand, is
overestimated by an average of 5.1% across all patients. The average lung voxel dose error
for these calculations is 1.7%. The corrected dose-to-medium distributions have average
bone, soft tissue, and lung dose errors of 0.0%, -0.3%, and -0.9% respectively, showing
considerable improvement over the model-based calculation alone. Mean dose errors range
from -3.6% to 2.5% for bone, -2.4% to 1.3% for soft tissue, and -1.7 to -0.3% for lung. Bone
voxels have the largest deviation in dose error, with an average standard deviation of 10.6%
for the corrected dose-to-water calculation. The average standard deviation dose errors are
3.0% for soft tissue and 2.8% for lung.
We also performed dose calculations for single-angle projection imaging procedures
in order to illustrate the suitability of the new algorithm for imaging modalities such as
fluoroscopy that make use of single incident beams. Figures IV.4, IV.5, and IV.6 show
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Table IV.2: Relative dose errors for the model-based calculation relative to the Monte
Carlo dose-to-medium calculation. Results for the model-based calculation that have been
corrected for medium-dependent effects, as well as uncorrected dose-to-water results are
shown relative to the maximum dose to soft tissue in the irradiated volume.
Dw corrected with MDC-EA (% ± 1 σ) Uncorrected Dw(% ± 1 σ)
Patient Bone Soft tissue Lung Bone Soft tissue Lung
Pelvis 1 2.5 ± 11.3 -1.8 ± 3.7 -1.7 ± 3.8 -67.4 ± 34.9 6.0 ± 4.3 -0.2 ± 2.7
Pelvis 2 2.0 ± 10.5 -2.4 ± 3.5 -1.1 ± 2.5 -63.5 ± 25.3 5.3 ± 4.0 -0.0 ± 1.6
Chest 1 -1.2 ± 10.4 0.4 ± 2.5 -1.3 ± 2.6 -79.3 ± 28.5 6.9 ± 4.1 3.6 ± 3.3
Chest 2 1.4 ± 6.7 1.3 ± 1.6 -1.7 ± 2.0 -47.6 ± 39.6 4.2 ± 2.8 2.2 ± 2.5
H&N 1 -1.0 ± 9.6 0.3 ± 2.9 -0.8 ± 2.2 -44.3 ± 43.4 3.9 ± 5.2 1.6 ± 3.9
H&N 2 -3.6 ± 11.4 -0.1 ± 3.0 -0.3 ± 2.8 -51.1 ± 37.9 4.2 ± 4.4 1.5 ± 3.8
H&N 3 -0.3 ± 14.2 0.4 ± 3.6 0.4 ± 3.4 -67.9 ± 35.2 5.5 ± 6.9 3.1 ± 6.1
example dose calculation results for simulated single projection imaging procedures done
on a head-and-neck, thoracic, and pelvis patients (patients H&N 1, Chest 1, and Pelvis 1
respectively). In each calculation the x-ray beam is anteriorly incident on the patient. The
x-ray beam used for these simulations was the pelvis beam.
IV.4 Discussion and conclusions
The new model-based dose calculation method for kilovoltage x-rays was tested for
calculating the imaging dose to patients from kV-CBCT imaging and single-angle projection
imaging. Used in conjunction with the MDC-EA to account for medium-dependent effects,
the new model-based approach resulted in mean dose errors of less than 4% for bone and
3% for soft tissues across all patients studied. Of note is that the medium-dependent
correction method adds minimal calculation time to the dose-to-water calculation as the
time consuming ray-tracing step can be used for both calculations. The dose-to-medium
distributions obtained in this chapter indicate that the dose calculation algorithm developed
in this dissertation has acceptable accuracy for the application of aggregating the radiation
dose from kV-CBCT image guidance procedures and single-angle projection imaging with
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(a) Transverse view of patient CT data
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(b) Monte Carlo dose-to-water
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(c) Monte Carlo dose-to-medium
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(d) Model-based dose-to-water
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(e) Model-based dose-to-medium
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(f) Anterior-to-posterior dose profile along the central
axis of the x-ray beam
Figure IV.4: Dose calculation results for a single anterior-to-posterior x-ray beam incident
on a head-and-neck patient (H&N 1).
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(a) Transverse view of patient CT data
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(b) Monte Carlo dose-to-water
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(c) Monte Carlo dose-to-medium
0 50 100 150
0
50
100
150
Model: dose-to-water 
0.0
0.4
0.8
1.2
1.6
2.0
2.4
2.8
3.2
3.6
d
o
se
 [
cG
y
/e
le
ct
ro
n
]
1e 20
(d) Model-based dose-to-water
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(e) Model-based dose-to-medium
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(f) Anterior-to-posterior dose profile along the central
axis of the x-ray beam
Figure IV.5: Dose calculation results for a single anterior-to-posterior x-ray beam incident
on a chest patient (Chest 1).
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(a) Monte Carlo dose-to-water
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(b) Monte Carlo dose-to-medium
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(c) Model-based dose-to-water
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(d) Model-based dose-to-medium
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(e) Anterior-to-posterior dose profile through the
femoral head
0 20 40 60 80 100 120 140 160 180
off-axis distance [voxel]
0.0
0.2
0.4
0.6
0.8
d
o
se
 [
cG
y
/e
le
ct
ro
n
]
1e 19
MC: dose-to-medium
Model: corrected with MDC-EA
MC: dose-to-water
Model: dose-to-water
(f) Superior-inferior dose profile
Figure IV.6: Dose calculation results for a single anterior-to-posterior x-ray beam incident
on a male pelvis patient (Pelvis 1).
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the therapeutic dose delivered during radiotherapy.
The results obtained for the single-angle projection imaging cases are indicative of
the calculation accuracy that can be expected when applying this algorithm to calculate the
radiation dose from superficial x-ray therapies since the energy of superficial x-ray beams
is comparable to the energies of the beams used to generate the results in this section. As
these x-ray beams are generally collimated to sizes that are small relative to the area of the
body being irradiated, the effects of phantom size on kernel generation should be minimized
in these situations. One potential difficulty in applying this algorithm to superficial x-ray
therapy calculations is that the area treated can be irregular in shape. For instance, the
treatment of a basal cell carcinoma on the nose may involve a beam that has an oblique
incidence. As Figure II.10 shows, the model-based calculation may overestimate the dose
to the surface of the patient in these situations.
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V Summary and conclusions
This work presents the first model-based dose calculation algorithm designed for
kilovoltage x-ray beams that includes the effects of photoabsorption in bone on the dose
distribution. Model-based convolution/superposition dose calculations are commonplace
in radiation therapy treatment planning systems where they are used to calculate patient
specific dose distributions resulting from megavoltage x-ray beams. The algorithm presented
in this dissertation extends the applicability of this class of algorithm to accurately calculate
the radiation dose to patients from the multitude of kilovoltage x-ray procedures used in
medicine including superficial and orthovoltage x-ray therapies, image-guidance procedures
in radiation therapy, and diagnostic procedures such as projection x-ray imaging and x-ray
computed tomography.
The new algorithm calculates radiation dose in two main steps: (1) a model-based
convolution/superposition algorithm is used to calculate the dose assuming that all media in
the calculation volume is equivalent in composition to water, but with density equal to the
actual media; (2) a medium-dependent correction method is used to obtain correction factor
distributions that account for perturbations to the dose distribution due to photoabsorption
of the x-ray beam in bone.
The dose-to-water calculation technique developed in this dissertation differs from
previous work in that our approach is the first model-based convolution/superposition
method designed from the ground up to calculate the dose from kilovoltage x-ray beams.
Adopting the model-based calculation framework and limiting the applicability of the al-
gorithm to the kilovoltage energy range has enabled us to invoke multiple approximations
that drastically simplify dose calculation yet result in acceptable accuracy for clinical ap-
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plications.
We presented two methods to obtain the medium-dependent correction factor: the
Medium-Dependent Correction: Direct Approach, and the Medium-Dependent Correction:
Effective Approach. The MDC-DA uses an empirical parameterization of the medium-
dependent correction factor as a function of depth along rays incident on the patient parallel
to the incident x-ray beam. This approach was shown to be accurate with the use of an
average model-parameter set, but improvements could be made if separate model parameter
sets were used for different imaging sites such as the head, thorax, and pelvis. The MDC-EA
improved on the accuracy of the MDC-DA method by correlating the medium-dependent
correction factor with a newly introduced quantity, the effective bone depth, that is easily
calculated from patient CT images. This method is preferable to the MDC-DA as a single set
of model parameters was sufficient to accurately calculate the medium-dependent correction
factor distributions for all imaging sites studied.
The algorithm described in this work can be extended to dose calculations for
arbitrary kilovoltage x-ray beams by fitting the dose-to-water model to Monte Carlo calcu-
lations as described in chapter II. For the x-ray beams studied in that chapter we found
that we could adjust the model to fit each beam simply by adjusting the ratio of the scat-
ter dose conversion factor to the primary dose conversion factor. For energies that differ
significantly from the range studied here more significant changes to the model parameters
may be necessary. Similarly, the MDC-EA model may require adjustment for x-ray beam
energies that differ from those studied here as the bone-to-water mass-energy absorption
coefficient ratio is highly dependent on energy. For the three beams included in chapter III,
however, we found that we could use a single set of correction factor curves regardless of
the kVp of the x-ray beam.
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The algorithm developed in this work can be used to accurately extend model-
based dose calculations to kilovoltage energy photon beams. The inability to account for
medium-dependent effects has long been a shortcoming of model-based dose calculation
algorithms. The algorithm presented in this work overcomes this deficiency, and makes
model-based dose calculations a suitable alternative to the Monte Carlo calculation tech-
nique which is currently the only method available for kilovoltage energy dose calculation.
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VI Appendix
VI.1 Summary of original contributions
In this section we summarize the original contributions to the dissertation that are
attributable to the author. The dissertation research was performed under the guidance and
supervision of Dr. George Ding, and many ideas are as a result of our close collaboration.
The Monte Carlo calculations used within this work were all performed by Dr. George
Ding.
The research culminating in this dissertation was performed during the period from
2008–2013. The author was enrolled as a full-time student in the Physics Ph.D. program
at Vanderbilt University from June 2009 to August 2010. After this time, the author was
employed full-time as a medical physicist at Centennial Medical Center in Nashville, TN,
and completed the remainder of the dissertation research as a part-time student.
From 2008–2011 we investigated the medium-dependent correction methods pre-
sented in chapter III. During this time, the author developed and implemented the two
algorithms presented in the dissertation: the MDC-DA, and the MDC-EA. The parameter-
ization of the medium-dependent effects used in the MDC-DA, and the introduction of the
effective bone depth to model these effects in the MDC-EA are attributable to the author.
These algorithms were published in separate journal articles [35, 66].
From 2011–2013 we investigated the problem of calculating the dose to water-
equivalent media. The dose-to-water calculation techniques were developed and imple-
mented by the author including the parameterization of the dose deposition model, the
monoenergetic approximation, introducing the effective density in the scatter dose calcula-
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tion, and neglecting kernel tilting in the scatter dose calculation. The author implemented
the ray-tracing algorithm and scatter dose convolution calculations to calculate the dose-
to-water.
The author implemented the algorithms developed within the dissertation to cal-
culate the radiation dose to real patients from x-ray imaging procedures. Benchmark cal-
culations and analyses were carried out by the author for each of the algorithms presented
to compare the accuracy of the model-based approach to Monte Carlo calculated dose dis-
tributions. At the time of writting the dissertation this work was being incorporated into a
manuscript being prepared for submission for publication.
In addition to the journal articles resulting from the dissertation research, the work
presented in this dissertation has been presented by the author at several national meetings
of the American Association of Physicists in Medicine [64, 65, 67].
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